1309946	Sodium	Gellens ME	Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel.	Proceedings of the National Academy of Sciences of the United States of America	1992	146
8819477	Sodium	Showalter VM	Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.	The Journal of pharmacology and experimental therapeutics	1996	129
11891345	Sodium	Maier SK	An unexpected role for brain-type sodium channels in coupling of cell surface depolarization to contraction in the heart.	Proceedings of the National Academy of Sciences of the United States of America	2002	84
16061851	Sodium	Fraser SP	Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis.	Clinical cancer research 	2005	93
17568746	Sodium	Zimmermann K	Sensory neuron sodium channel Nav1.8 is essential for pain at low temperatures.	Nature	2007	105
18439620	Sodium	Sossalla S	Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation.	Journal of molecular and cellular cardiology	2008	59
20038812	Sodium	Jarecki BW	Human voltage-gated sodium channel mutations that cause inherited neuronal and muscle channelopathies increase resurgent sodium currents.	The Journal of clinical investigation	2010	42
23232607	Sodium	Dib-Hajj SD	The Na(V)1.7 sodium channel: from molecule to man.	Nature reviews. Neuroscience	2013	100
23608660	Sodium	Hyndman KA	Renal collecting duct NOS1 maintains fluid-electrolyte homeostasis and blood pressure.	Hypertension	2013	29
23640885	Sodium	Shavkunov AS	The fibroblast growth factor 14·voltage-gated sodium channel complex is a new target of glycogen synthase kinase 3 (GSK3).	The Journal of biological chemistry	2013	36
23741036	Sodium	Hargus NJ	Evidence for a role of Nav1.6 in facilitating increases in neuronal hyperexcitability during epileptogenesis.	Journal of neurophysiology	2013	27
25250572	Sodium	McCormick JA	Hyperkalemic hypertension-associated cullin 3 promotes WNK signaling by degrading KLHL3.	The Journal of clinical investigation	2014	31
25927480	Sodium	de Lera Ruiz M	Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications.	Journal of medicinal chemistry	2015	16
27141060	Sodium	Norlander AE	Interleukin-17A Regulates Renal Sodium Transporters and Renal Injury in Angiotensin II-Induced Hypertension.	Hypertension	2016	14
27270488	Sodium	Meisler MH	SCN8A encephalopathy: Research progress and prospects.	Epilepsia	2016	17
9348186	Estradiol	Couse JF	Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse.	Endocrinology	1997	136
15090535	Estradiol	Maggiolini M	The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells.	The Journal of biological chemistry	2004	126
15798185	Estradiol	Ghisletti S	17beta-estradiol inhibits inflammatory gene expression by controlling NF-kappaB intracellular localization.	Molecular and cellular biology	2005	88
18164232	Estradiol	Osburn WO	Nrf2 signaling: an adaptive response pathway for protection against environmental toxic insults.	Mutation research	2008	105
18817753	Estradiol	Puga A	The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways.	Biochemical pharmacology	2009	90
18838122	Estradiol	Lau A	Dual roles of Nrf2 in cancer.	Pharmacological research	2008	181
20351193	Estradiol	Murphy AJ	Estradiol suppresses NF-kappa B activation through coordinated regulation of let-7a and miR-125b in primary human macrophages.	Journal of immunology	2010	49
20404318	Estradiol	Vivar OI	Estrogen receptor beta binds to and regulates three distinct classes of target genes.	The Journal of biological chemistry	2010	41
27028912	Estradiol	Hodis HN	Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol.	The New England journal of medicine	2016	31
10331074	Estrogens	Guengerich FP	Cytochrome P-450 3A4: regulation and role in drug metabolism.	Annual review of pharmacology and toxicology	1999	171
16112414	Estrogens	Tsuchiya Y	Cytochrome P450-mediated metabolism of estrogens and its regulation in human.	Cancer letters	2005	99
16938840	Estrogens	Leung YK	Estrogen receptor (ER)-beta isoforms: a key to understanding ER-beta signaling.	Proceedings of the National Academy of Sciences of the United States of America	2006	101
17284330	Estrogens	Timsit YE	CAR and PXR: the xenobiotic-sensing receptors.	Steroids	2007	91
20501637	Estrogens	Leung YK	Estrogen receptor beta2 and beta5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion.	Endocrine-related cancer	2010	43
21639909	Estrogens	Tam A	The role of female hormones on lung function in chronic lung diseases.	BMC women's health	2011	36
22648069	Estrogens	Burns KA	Estrogen receptors and human disease: an update.	Archives of toxicology	2012	44
24954179	Estrogens	Bondesson M	Estrogen receptor signaling during vertebrate development.	Biochimica et biophysica acta	2015	23
25012808	Estrogens	Huang R	Profiling of the Tox21 10K compound library for agonists and antagonists of the estrogen receptor alpha signaling pathway.	Scientific reports	2014	22
25206307	Estrogens	Hosford SR	Clinical potential of novel therapeutic targets in breast cancer: CDK4/6, Src, JAK/STAT, PARP, HDAC, and PI3K/AKT/mTOR pathways.	Pharmacogenomics and personalized medicine	2014	27
26272952	Estrogens	Judson RS	Integrated Model of Chemical Perturbations of a Biological Pathway Using 18 In Vitro High-Throughput Screening Assays for the Estrogen Receptor.	Toxicological sciences 	2015	26
27277684	Estrogens	Singh R	Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis.	Cell death & disease	2016	12
27725895	Estrogens	Hon JD	Breast cancer molecular subtypes: from TNBC to QNBC.	American journal of cancer research	2016	11
15998259	Insulin	Evans JL	The molecular basis for oxidative stress-induced insulin resistance.	Antioxidants & redox signaling	2005	87
16445986	Insulin	Summers SA	Ceramides in insulin resistance and lipotoxicity.	Progress in lipid research	2006	209
17374708	Insulin	Anderson PD	Innate immunity modulates adipokines in humans.	The Journal of clinical endocrinology and metabolism	2007	57
18197261	Insulin	Chao KC	Islet-like clusters derived from mesenchymal stem cells in Wharton's Jelly of the human umbilical cord for transplantation to control type 1 diabetes.	PloS one	2008	70
18769445	Insulin	Cohen E	The insulin paradox: aging, proteotoxicity and neurodegeneration.	Nature reviews. Neuroscience	2008	94
19207680	Insulin	Ricchi M	Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes.	Journal of gastroenterology and hepatology	2009	83
19406747	Insulin	Zhao WQ	Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric a{beta}.	The Journal of biological chemistry	2009	47
19755625	Insulin	Ghanim H	Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance.	Diabetes care	2009	106
20225248	Insulin	Gupta NA	Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway.	Hepatology	2010	79
21705062	Insulin	Tahrani AA	Management of type 2 diabetes: new and future developments in treatment.	Lancet	2011	74
22330739	Insulin	Tiano JP	Importance of oestrogen receptors to preserve functional β-cell mass in diabetes.	Nature reviews. Endocrinology	2012	41
22476196	Insulin	Bomfim TR	An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.	The Journal of clinical investigation	2012	123
23349537	Insulin	Costes S	β-Cell failure in type 2 diabetes: a case of asking too much of too few?	Diabetes	2013	31
24174327	Insulin	Finan B	Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans.	Science translational medicine	2013	27
24380887	Insulin	de la Monte SM	Brain metabolic dysfunction at the core of Alzheimer's disease.	Biochemical pharmacology	2014	55
25036708	Insulin	Rivera JF	Autophagy defends pancreatic β cells from human islet amyloid polypeptide-induced toxicity.	The Journal of clinical investigation	2014	49
26212089	Insulin	Kapil S	Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease.	Journal of gastroenterology and hepatology	2016	12
27376324	Insulin	Yoon MS	The Emerging Role of Branched-Chain Amino Acids in Insulin Resistance and Metabolism.	Nutrients	2016	16
27527746	Insulin	Feldman A	Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver.	The American journal of gastroenterology	2017	11
27916275	Insulin	Li J	Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity.	Cell	2017	22
2993906	Peptides	Cuttitta F	Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer.	Nature	1985	169
10768988	Peptides	Krisanaprakornkit S	Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier.	Infection and immunity	2000	97
15691826	Peptides	Furukawa Y	Amyotrophic lateral sclerosis mutations have the greatest destabilizing effect on the apo- and reduced form of SOD1, leading to unfolding and oxidative aggregation.	The Journal of biological chemistry	2005	83
15932924	Peptides	Talsania T	Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice.	Endocrinology	2005	67
16293630	Peptides	Rosenfeld Y	Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action.	The Journal of biological chemistry	2006	68
17191902	Peptides	Seebach D	The world of beta- and gamma-peptides comprised of homologated proteinogenic amino acids and other components.	Chemistry & biodiversity	2004	73
18056480	Peptides	Farhat K	Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling.	Journal of leukocyte biology	2008	83
18216022	Peptides	Liu Z	Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation.	The Journal of biological chemistry	2008	71
18287102	Peptides	Runge S	Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain.	The Journal of biological chemistry	2008	104
19089837	Peptides	Veiseh O	Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles.	Small	2009	51
19179531	Peptides	Junker JP	Ligand-dependent equilibrium fluctuations of single calmodulin molecules.	Science	2009	61
19581601	Peptides	Britschgi M	Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	2009	46
19949402	Peptides	Wulff H	Voltage-gated potassium channels as therapeutic targets.	Nature reviews. Drug discovery	2009	168
20068138	Peptides	Arakawa M	Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4.	Diabetes	2010	102
20172966	Peptides	Ban K	Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.	Endocrinology	2010	54
20215461	Peptides	Buse JB	DURATION-1: exenatide once weekly produces sustained glycemic control and weight loss over 52 weeks.	Diabetes care	2010	56
20595511	Peptides	Wild D	Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT.	Journal of nuclear medicine 	2010	44
20929995	Peptides	Best JH	Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the LifeLink database.	Diabetes care	2011	57
21297667	Peptides	Switzer CH	Targeting SET/I(2)PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy.	Oncogene	2011	42
21334333	Peptides	Elashoff M	Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies.	Gastroenterology	2011	136
21696149	Peptides	Bae C	The mechanosensitive ion channel Piezo1 is inhibited by the peptide GsMTx4.	Biochemistry	2011	76
21920963	Peptides	Lønborg J	Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction.	European heart journal	2012	75
22471248	Peptides	Deacon CF	Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis.	Diabetes, obesity & metabolism	2012	34
22565812	Peptides	Müller TD	Restoration of leptin responsiveness in diet-induced obese mice using an optimized leptin analog in combination with exendin-4 or FGF21.	Journal of peptide science 	2012	33
22862847	Peptides	Niswender K	Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme.	Diabetes, obesity & metabolism	2013	31
23141817	Peptides	Buse JB	Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study.	Lancet	2013	88
23213206	Peptides	Mazor R	Identification and elimination of an immunodominant T-cell epitope in recombinant immunotoxins based on Pseudomonas exotoxin A.	Proceedings of the National Academy of Sciences of the United States of America	2012	34
23297075	Peptides	Wu Z	Development and evaluation of 18F-TTCO-Cys40-Exendin-4: a PET probe for imaging transplanted islets.	Journal of nuclear medicine 	2013	32
23440284	Peptides	Singh S	Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study.	JAMA internal medicine	2013	66
23479653	Peptides	Wootten D	Polar transmembrane interactions drive formation of ligand-specific and signal pathway-biased family B G protein-coupled receptor conformations.	Proceedings of the National Academy of Sciences of the United States of America	2013	38
23829656	Peptides	Monami M	Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk: a meta-analysis of randomized clinical trials.	Diabetes, obesity & metabolism	2014	26
23868944	Peptides	Woo JS	Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.	Arteriosclerosis, thrombosis, and vascular biology	2013	31
24263424	Peptides	Katout M	Effect of GLP-1 mimetics on blood pressure and relationship to weight loss and glycemia lowering: results of a systematic meta-analysis and meta-regression.	American journal of hypertension	2014	21
24325867	Peptides	Gomez-Sanchez CE	Development of monoclonal antibodies against human CYP11B1 and CYP11B2.	Molecular and cellular endocrinology	2014	51
24655583	Peptides	Kim YG	Differences in the HbA1c-lowering efficacy of glucagon-like peptide-1 analogues between Asians and non-Asians: a systematic review and meta-analysis.	Diabetes, obesity & metabolism	2014	27
24731672	Peptides	Diamant M	Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trial.	The lancet. Diabetes & endocrinology	2014	25
25071023	Peptides	van Bloemendaal L	GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans.	Diabetes	2014	42
25645567	Peptides	Blonde L	Association among weight change, glycemic control, and markers of cardiovascular risk with exenatide once weekly: a pooled analysis of patients with type 2 diabetes.	Cardiovascular diabetology	2015	17
26995376	Peptides	Holman RR	Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial.	American heart journal	2016	10
27315480	Peptides	Wootten D	The Extracellular Surface of the GLP-1 Receptor Is a Molecular Trigger for Biased Agonism.	Cell	2016	16
11705489	Glucose	van Oosterom AT	Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study.	Lancet	2001	155
14622599	Glucose	Manel N	The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV.	Cell	2003	112
16144950	Glucose	Fehse F	Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes.	The Journal of clinical endocrinology and metabolism	2005	68
16873530	Glucose	Chung S	Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes.	Endocrinology	2006	61
17328689	Glucose	Mattson MP	Calcium and neurodegeneration.	Aging cell	2007	168
19074620	Glucose	Kim W	The role of incretins in glucose homeostasis and diabetes treatment.	Pharmacological reviews	2008	141
19794059	Glucose	Mehta NN	Experimental endotoxemia induces adipose inflammation and insulin resistance in humans.	Diabetes	2010	88
20067961	Glucose	Deopurkar R	Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3.	Diabetes care	2010	55
20103708	Glucose	Jiang T	The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy.	Diabetes	2010	78
20200256	Glucose	Ghanim H	Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and Toll-like receptor expression.	The American journal of clinical nutrition	2010	61
20497976	Glucose	Widyantoro B	Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition.	Circulation	2010	85
21425331	Glucose	Pi M	GPRC6A mediates responses to osteocalcin in β-cells in vitro and pancreas in vivo.	Journal of bone and mineral research 	2011	49
21670502	Glucose	Liao X	Krüppel-like factor 4 regulates macrophage polarization.	The Journal of clinical investigation	2011	147
22191795	Glucose	de la Monte SM	Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.	Drugs	2012	43
22318237	Glucose	Peters JM	The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention.	Nature reviews. Cancer	2012	103
22572877	Glucose	Cani PD	Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity.	Gut microbes	2012	81
22682222	Glucose	Haschemi A	The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism.	Cell metabolism	2012	88
23160966	Glucose	Piya MK	Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin.	The Journal of endocrinology	2013	45
23886976	Glucose	Geurts L	Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.	Beneficial microbes	2014	46
24723555	Glucose	Gaens KH	Nε-(carboxymethyl)lysine-receptor for advanced glycation end product axis is a key modulator of obesity-induced dysregulation of adipokine expression and insulin resistance.	Arteriosclerosis, thrombosis, and vascular biology	2014	25
24846769	Glucose	Ghosh S	Elevated muscle TLR4 expression and metabolic endotoxemia in human aging.	The journals of gerontology. Series A, Biological sciences and medical sciences	2015	25
25046320	Glucose	Wirth MD	Association of a dietary inflammatory index with inflammatory indices and metabolic syndrome among police officers.	Journal of occupational and environmental medicine	2014	65
25149919	Glucose	Pfeifer A	Brown, beige, and white: the new color code of fat and its pharmacological implications.	Annual review of pharmacology and toxicology	2015	21
25304002	Glucose	Vrhovac I	Localizations of Na(+)-D-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart.	Pflugers Archiv 	2015	23
25340307	Glucose	Zhu L	Cellular metabolism and macrophage functional polarization.	International reviews of immunology	2015	22
25733469	Glucose	van Bussel BC	A healthy diet is associated with less endothelial dysfunction and less low-grade inflammation over a 7-year period in adults at risk of cardiovascular disease.	The Journal of nutrition	2015	16
26386558	Glucose	Ti D	LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b.	Journal of translational medicine	2015	22
26453144	Glucose	Bock KW	The UDP-glycosyltransferase (UGT) superfamily expressed in humans, insects and plants: Animal-plant arms-race and co-evolution.	Biochemical pharmacology	2016	13
26718502	Glucose	Long M	An Essential Role of NRF2 in Diabetic Wound Healing.	Diabetes	2016	14
12717385	Ethanol	Paik YH	Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells.	Hepatology	2003	166
14744237	Ethanol	Caro AA	Oxidative stress, toxicology, and pharmacology of CYP2E1.	Annual review of pharmacology and toxicology	2004	93
15670660	Ethanol	Lieber CS	Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis.	Alcohol	2004	141
16573591	Ethanol	Crews FT	Cytokines and alcohol.	Alcoholism, clinical and experimental research	2006	104
17466744	Ethanol	Witt H	Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy.	Gastroenterology	2007	95
17726039	Ethanol	Gunnell D	The impact of pesticide regulations on suicide in Sri Lanka.	International journal of epidemiology	2007	70
18575590	Ethanol	Ancuta P	Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients.	PloS one	2008	198
18666317	Ethanol	Gomaa AI	Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis.	World journal of gastroenterology	2008	139
19250206	Ethanol	Berasain C	Inflammation and liver cancer: new molecular links .	Annals of the New York Academy of Sciences	2009	113
19362087	Ethanol	Fortunato F	Impaired autolysosome formation correlates with Lamp-2 depletion: role of apoptosis, autophagy, and necrosis in pancreatitis.	Gastroenterology	2009	69
20238398	Ethanol	Szabo G	Alcoholic liver disease and the gut-liver axis.	World journal of gastroenterology	2010	101
20451455	Ethanol	Marur S	HPV-associated head and neck cancer: a virus-related cancer epidemic.	The Lancet. Oncology	2010	313
20639898	Ethanol	Whittaker S	The role of signaling pathways in the development and treatment of hepatocellular carcinoma.	Oncogene	2010	208
21878650	Ethanol	Yadav S	miR-497 and miR-302b regulate ethanol-induced neuronal cell death through BCL2 protein and cyclin D2.	The Journal of biological chemistry	2011	50
21985328	Ethanol	Trepanier CH	Regulation of NMDA receptors by the tyrosine kinase Fyn.	The FEBS journal	2012	41
22427130	Ethanol	Volynets V	Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD).	Digestive diseases and sciences	2012	33
24400890	Ethanol	McDaniel K	The functional role of microRNAs in alcoholic liver injury.	Journal of cellular and molecular medicine	2014	34
25278688	Ethanol	Williams JA	New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases.	World journal of gastroenterology	2014	20
25465468	Ethanol	Song BJ	Mitochondrial dysfunction and tissue injury by alcohol, high fat, nonalcoholic substances and pathological conditions through post-translational protein modifications.	Redox biology	2014	20
26482880	Ethanol	Buch S	A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis.	Nature genetics	2015	35
26683974	Ethanol	Valenta JP	Chronic Intracerebroventricular Infusion of Monocyte Chemoattractant Protein-1 Leads to a Persistent Increase in Sweetened Ethanol Consumption During Operant Self-Administration But Does Not Influence Sucrose Consumption in Long-Evans Rats.	Alcoholism, clinical and experimental research	2016	11
26769846	Ethanol	Wang S	Increased hepatic receptor interacting protein kinase 3 expression due to impaired proteasomal functions contributes to alcohol-induced steatosis and liver injury.	Oncotarget	2016	11
28257851	Ethanol	Lachenmeier DW	ALDH2-deficiency as genetic epidemiologic and biochemical model for the carcinogenicity of acetaldehyde.	Regulatory toxicology and pharmacology 	2017	6
8947031	Copper	Petris MJ	Ligand-regulated transport of the Menkes copper P-type ATPase efflux pump from the Golgi apparatus to the plasma membrane: a novel mechanism of regulated trafficking.	The EMBO journal	1996	116
12966034	Copper	Wang J	Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature.	Human molecular genetics	2003	98
14676042	Copper	Ritchie CW	Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial.	Archives of neurology	2003	154
15326189	Copper	Arnesano F	The unusually stable quaternary structure of human Cu,Zn-superoxide dismutase 1 is controlled by both metal occupancy and disulfide status.	The Journal of biological chemistry	2004	76
17018581	Copper	Bowler RM	Dose-effect relationships between manganese exposure and neurological, neuropsychological and pulmonary function in confined space bridge welders.	Occupational and environmental medicine	2007	59
21332300	Copper	Cho WS	Differential pro-inflammatory effects of metal oxide nanoparticles and their soluble ions in vitro and in vivo; zinc and copper nanoparticles, but not their ions, recruit eosinophils to the lungs.	Nanotoxicology	2012	44
21487404	Copper	Yip NC	Disulfiram modulated ROS-MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties.	British journal of cancer	2011	51
22307640	Copper	You H	Aβ neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-D-aspartate receptors.	Proceedings of the National Academy of Sciences of the United States of America	2012	54
24909901	Copper	Polishchuk EV	Wilson disease protein ATP7B utilizes lysosomal exocytosis to maintain copper homeostasis.	Developmental cell	2014	35
25890736	Copper	Zhao S	Wound dressings composed of copper-doped borate bioactive glass microfibers stimulate angiogenesis and heal full-thickness skin defects in a rodent model.	Biomaterials	2015	16
26657039	Copper	Kaur SJ	Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis.	Gene	2016	20
15249177	Zinc	Pikkarainen S	GATA transcription factors in the developing and adult heart.	Cardiovascular research	2004	93
15592454	Zinc	Breidenbach MA	Substrate recognition strategy for botulinum neurotoxin serotype A.	Nature	2004	103
18253864	Zinc	Brayer KJ	Keep your fingers off my DNA: protein-protein interactions mediated by C2H2 zinc finger domains.	Cell biochemistry and biophysics	2008	89
19339596	Zinc	Deshpande A	A role for synaptic zinc in activity-dependent Abeta oligomer formation and accumulation at excitatory synapses.	The Journal of neuroscience 	2009	67
19909263	Zinc	Lee JE	Pathogenic mechanisms of myotonic dystrophy.	Biochemical Society transactions	2009	97
20617034	Zinc	Plum LM	The essential toxin: impact of zinc on human health.	International journal of environmental research and public health	2010	67
20974010	Zinc	Lee SJ	Roles of zinc and metallothionein-3 in oxidative stress-induced lysosomal dysfunction, cell death, and autophagy in neurons and astrocytes.	Molecular brain	2010	46
21575912	Zinc	Ramirez-Ortiz ZG	A nonredundant role for plasmacytoid dendritic cells in host defense against the human fungal pathogen Aspergillus fumigatus.	Cell host & microbe	2011	39
21622571	Zinc	Hadian K	NF-κB essential modulator (NEMO) interaction with linear and lys-63 ubiquitin chains contributes to NF-κB activation.	The Journal of biological chemistry	2011	39
21813459	Zinc	Mussolino C	A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity.	Nucleic acids research	2011	241
21925112	Zinc	Botella H	Mycobacterial p(1)-type ATPases mediate resistance to zinc poisoning in human macrophages.	Cell host & microbe	2011	85
22341971	Zinc	Quadri M	Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease.	American journal of human genetics	2012	65
24399444	Zinc	Park JS	Parkinson's disease-associated human ATP13A2 (PARK9) deficiency causes zinc dyshomeostasis and mitochondrial dysfunction.	Human molecular genetics	2014	32
24518294	Zinc	Truong HH	β1 integrin inhibition elicits a prometastatic switch through the TGFβ-miR-200-ZEB network in E-cadherin-positive triple-negative breast cancer.	Science signaling	2014	23
25964473	Zinc	Haley KP	The Human Antimicrobial Protein Calgranulin C Participates in Control of Helicobacter pylori Growth and Regulation of Virulence.	Infection and immunity	2015	15
26614004	Zinc	Rosenkranz E	Zinc supplementation induces regulatory T cells by inhibition of Sirt-1 deacetylase in mixed lymphocyte cultures.	Molecular nutrition & food research	2016	10
10748254	Iron	Guerinot ML	The ZIP family of metal transporters.	Biochimica et biophysica acta	2000	136
11113132	Iron	Pigeon C	A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload.	The Journal of biological chemistry	2001	327
11438811	Iron	Curtis AR	Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease.	Nature genetics	2001	92
12522003	Iron	Ludwiczek S	Cytokine-mediated regulation of iron transport in human monocytic cells.	Blood	2003	81
14980223	Iron	Cheng Y	Structure of the human transferrin receptor-transferrin complex.	Cell	2004	107
15886319	Iron	Kemna E	Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS.	Blood	2005	110
16801541	Iron	Truksa J	Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6.	Proceedings of the National Academy of Sciences of the United States of America	2006	97
16920030	Iron	Daniels TR	The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells.	Clinical immunology	2006	96
18166790	Iron	Kemna EH	Hepcidin: from discovery to differential diagnosis.	Haematologica	2008	55
18327971	Iron	MacKenzie EL	Intracellular iron transport and storage: from molecular mechanisms to health implications.	Antioxidants & redox signaling	2008	76
20453089	Iron	de Vries SP	Genome analysis of Moraxella catarrhalis strain BBH18, corrected a human respiratory tract pathogen.	Journal of bacteriology	2010	43
20542038	Iron	Pietrangelo A	Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment.	Gastroenterology	2010	87
20580464	Iron	Sierra-Filardi E	Heme Oxygenase-1 expression in M-CSF-polarized M2 macrophages contributes to LPS-induced IL-10 release.	Immunobiology	2010	54
21238504	Iron	Khan AA	Control of intracellular heme levels: heme transporters and heme oxygenases.	Biochimica et biophysica acta	2011	50
21589640	Iron	Echenique-Rivera H	Transcriptome analysis of Neisseria meningitidis in human whole blood and mutagenesis studies identify virulence factors involved in blood survival.	PLoS pathogens	2011	61
21855608	Iron	Brissot P	Non-transferrin bound iron: a key role in iron overload and iron toxicity.	Biochimica et biophysica acta	2012	82
21992109	Iron	Grochot-Przeczek A	Haem oxygenase-1: non-canonical roles in physiology and pathology.	Clinical science	2012	46
22085723	Iron	Gkouvatsos K	Regulation of iron transport and the role of transferrin.	Biochimica et biophysica acta	2012	60
22611157	Iron	Besson-Fournier C	Induction of activin B by inflammatory stimuli up-regulates expression of the iron-regulatory peptide hepcidin through Smad1/5/8 signaling.	Blood	2012	56
23632016	Iron	Guengerich FP	Unusual cytochrome p450 enzymes and reactions.	The Journal of biological chemistry	2013	38
23640898	Iron	Leidgens S	Each member of the poly-r(C)-binding protein 1 (PCBP) family exhibits iron chaperone activity toward ferritin.	The Journal of biological chemistry	2013	29
24622774	Iron	Schuh C	Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models.	Acta neuropathologica	2014	20
25389409	Iron	Schaer DJ	Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug development.	Frontiers in physiology	2014	34
26385212	Iron	de Swart L	Second international round robin for the quantification of serum non-transferrin-bound iron and labile plasma iron in patients with iron-overload disorders.	Haematologica	2016	11
10839541	Acetylcholine	Borovikova LV	Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin.	Nature	2000	603
12508119	Acetylcholine	Wang H	Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation.	Nature	2003	567
12805474	Acetylcholine	Terry AV Jr	The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development.	The Journal of pharmacology and experimental therapeutics	2003	106
12869558	Acetylcholine	Nicolet Y	Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products.	The Journal of biological chemistry	2003	93
15502843	Acetylcholine	Wang H	Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis.	Nature medicine	2004	261
16330682	Acetylcholine	Dobrev D	The G protein-gated potassium current I(K,ACh) is constitutively active in patients with chronic atrial fibrillation.	Circulation	2005	74
17167421	Acetylcholine	Jin R	Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity.	Nature	2006	64
18381563	Acetylcholine	Kuryatov A	Roles of accessory subunits in alpha4beta2(*) nicotinic receptors.	Molecular pharmacology	2008	84
19126755	Acetylcholine	Albuquerque EX	Mammalian nicotinic acetylcholine receptors: from structure to function.	Physiological reviews	2009	403
21814823	Acetylcholine	Pevzner A	Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis.	Journal of neurology	2012	39
24240280	Acetylcholine	Benoit RM	Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A.	Nature	2014	22
24849809	Acetylcholine	Lu B	α7 nicotinic acetylcholine receptor signaling inhibits inflammasome activation by preventing mitochondrial DNA release.	Molecular medicine	2014	21
25575180	Acetylcholine	Madden L	Bioengineered human myobundles mimic clinical responses of skeletal muscle to drugs.	eLife	2015	36
10328216	Adenosine Diphosphate	Fritz G	Rho GTPases are over-expressed in human tumors.	International journal of cancer	1999	171
15959561	Adenosine Diphosphate	Malanga M	The role of poly(ADP-ribose) in the DNA damage signaling network.	Biochemistry and cell biology = Biochimie et biologie cellulaire	2005	84
18191792	Adenosine Diphosphate	Spanò S	Delivery of a Salmonella Typhi exotoxin from a host intracellular compartment.	Cell host & microbe	2008	56
19182783	Adenosine Diphosphate	Sáenz JB	Golgicide A reveals essential roles for GBF1 in Golgi assembly and function.	Nature chemical biology	2009	69
19220204	Adenosine Diphosphate	Vanhoutte PM	Endothelial dysfunction and vascular disease.	Acta physiologica	2009	134
21974986	Adenosine Diphosphate	Otvos L Jr	Design and development of a peptide-based adiponectin receptor agonist for cancer treatment.	BMC biotechnology	2011	37
22517902	Adenosine Diphosphate	Flamm MH	Multiscale prediction of patient-specific platelet function under flow.	Blood	2012	35
22731697	Adenosine Diphosphate	Zhang D	Polymorphic toxin systems: Comprehensive characterization of trafficking modes, processing, mechanisms of action, immunity and ecology using comparative genomics.	Biology direct	2012	108
23357755	Adenosine Diphosphate	Kraus WL	PARP-1 and gene regulation: progress and puzzles.	Molecular aspects of medicine	2013	58
23535599	Adenosine Diphosphate	Burnaevskiy N	Proteolytic elimination of N-myristoyl modifications by the Shigella virulence factor IpaJ.	Nature	2013	35
24075860	Adenosine Diphosphate	Seo GJ	Reciprocal inhibition between intracellular antiviral signaling and the RNAi machinery in mammalian cells.	Cell host & microbe	2013	57
24919149	Adenosine Diphosphate	Xu H	Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome.	Nature	2014	101
26091343	Adenosine Diphosphate	Bai P	Biology of Poly(ADP-Ribose) Polymerases: The Factotums of Cell Maintenance.	Molecular cell	2015	32
26824338	Adenosine Diphosphate	Zakraoui O	Lebein, a snake venom disintegrin, suppresses human colon cancer cells proliferation and tumor-induced angiogenesis through cell cycle arrest, apoptosis induction and inhibition of VEGF expression.	Molecular carcinogenesis	2017	7
9053458	Adenosine Triphosphate	Ferrari D	Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin.	The Journal of experimental medicine	1997	108
9126928	Adenosine Triphosphate	Leist M	Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis.	The Journal of experimental medicine	1997	277
10233156	Adenosine Triphosphate	Andrei C	The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles.	Molecular biology of the cell	1999	118
15717060	Adenosine Triphosphate	Löscher W	Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.	NeuroRx 	2005	111
16208377	Adenosine Triphosphate	Akeda Y	Chaperone release and unfolding of substrates in type III secretion.	Nature	2005	153
16251956	Adenosine Triphosphate	Myong S	Repetitive shuttling of a motor protein on DNA.	Nature	2005	110
16305368	Adenosine Triphosphate	Glavinas H	The role of ABC transporters in drug resistance, metabolism and toxicity.	Current drug delivery	2004	91
16518375	Adenosine Triphosphate	Szakács G	Targeting multidrug resistance in cancer.	Nature reviews. Drug discovery	2006	621
16543131	Adenosine Triphosphate	Ishibashi T	Astrocytes promote myelination in response to electrical impulses.	Neuron	2006	179
17717039	Adenosine Triphosphate	de Bie P	Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes.	Journal of medical genetics	2007	62
17763411	Adenosine Triphosphate	Gattorno M	Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations.	Arthritis and rheumatism	2007	68
17952660	Adenosine Triphosphate	Wirkner K	P2X3 receptor involvement in pain states.	Molecular neurobiology	2007	59
18154452	Adenosine Triphosphate	Sharom FJ	ABC multidrug transporters: structure, function and role in chemoresistance.	Pharmacogenomics	2008	173
18454141	Adenosine Triphosphate	Tasdemir E	Regulation of autophagy by cytoplasmic p53.	Nature cell biology	2008	333
18704197	Adenosine Triphosphate	Lo Bianco C	Hsp104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease.	The Journal of clinical investigation	2008	60
18779046	Adenosine Triphosphate	Yu HB	The caspase-1 inflammasome: a pilot of innate immune responses.	Cell host & microbe	2008	73
19008857	Adenosine Triphosphate	Nishida M	P2Y6 receptor-Galpha12/13 signalling in cardiomyocytes triggers pressure overload-induced cardiac fibrosis.	The EMBO journal	2008	54
19104081	Adenosine Triphosphate	Netea MG	Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages.	Blood	2009	211
19428331	Adenosine Triphosphate	Lucas R	Regulators of endothelial and epithelial barrier integrity and function in acute lung injury.	Biochemical pharmacology	2009	63
19788499	Adenosine Triphosphate	Vähäkangas K	Drug transporters in the human blood-placental barrier.	British journal of pharmacology	2009	51
19805629	Adenosine Triphosphate	Lamkanfi M	Glyburide inhibits the Cryopyrin/Nalp3 inflammasome.	The Journal of cell biology	2009	176
20004485	Adenosine Triphosphate	Kis O	The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters.	Trends in pharmacological sciences	2010	64
20167368	Adenosine Triphosphate	Szydlowska K	Calcium, ischemia and excitotoxicity.	Cell calcium	2010	126
20413686	Adenosine Triphosphate	Rawat R	Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle.	The American journal of pathology	2010	45
20644254	Adenosine Triphosphate	Imtiyaz HZ	Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation.	The Journal of clinical investigation	2010	98
20875415	Adenosine Triphosphate	Hwang SJ	β-nicotinamide adenine dinucleotide is an enteric inhibitory neurotransmitter in human and nonhuman primate colons.	Gastroenterology	2011	41
21767633	Adenosine Triphosphate	Grune T	HSP70 mediates dissociation and reassociation of the 26S proteasome during adaptation to oxidative stress.	Free radical biology & medicine	2011	49
21878559	Adenosine Triphosphate	Hardwick RN	Variations in ATP-binding cassette transporter regulation during the progression of human nonalcoholic fatty liver disease.	Drug metabolism and disposition	2011	40
21915284	Adenosine Triphosphate	Eltom S	P2X7 receptor and caspase 1 activation are central to airway inflammation observed after exposure to tobacco smoke.	PloS one	2011	49
21967057	Adenosine Triphosphate	Sharom FJ	The P-glycoprotein multidrug transporter.	Essays in biochemistry	2011	73
22003197	Adenosine Triphosphate	Hoegen T	The NLRP3 inflammasome contributes to brain injury in pneumococcal meningitis and is activated through ATP-dependent lysosomal cathepsin B release.	Journal of immunology	2011	46
22098950	Adenosine Triphosphate	Nakanishi T	Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression.	Chinese journal of cancer	2012	49
22509477	Adenosine Triphosphate	Mo W	Human ABCG2: structure, function, and its role in multidrug resistance.	International journal of biochemistry and molecular biology	2012	37
22544529	Adenosine Triphosphate	Franke H	Pathophysiology of astroglial purinergic signalling.	Purinergic signalling	2012	34
22561706	Adenosine Triphosphate	Dhar SK	Manganese superoxide dismutase regulation and cancer.	Free radical biology & medicine	2012	51
22635270	Adenosine Triphosphate	Atsumi S	Single amino acid mutation in an ATP-binding cassette transporter gene causes resistance to Bt toxin Cry1Ab in the silkworm, Bombyx mori.	Proceedings of the National Academy of Sciences of the United States of America	2012	39
22750882	Adenosine Triphosphate	Chambers SM	Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors.	Nature biotechnology	2012	103
23298398	Adenosine Triphosphate	Strazielle N	Physiology of blood-brain interfaces in relation to brain disposition of small compounds and macromolecules.	Molecular pharmaceutics	2013	34
23430704	Adenosine Triphosphate	Finka A	Proteomic data from human cell cultures refine mechanisms of chaperone-mediated protein homeostasis.	Cell stress & chaperones	2013	49
23483818	Adenosine Triphosphate	Basaranoglu M	From fatty liver to fibrosis: a tale of "second hit".	World journal of gastroenterology	2013	39
23688078	Adenosine Triphosphate	Choi YH	ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development.	Current pharmaceutical design	2014	42
23878142	Adenosine Triphosphate	Asgari E	C3a modulates IL-1β secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation.	Blood	2013	53
24332968	Adenosine Triphosphate	Tornovsky-Babeay S	Type 2 diabetes and congenital hyperinsulinism cause DNA double-strand breaks and p53 activity in β cells.	Cell metabolism	2014	32
24481253	Adenosine Triphosphate	Bulau AM	Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses.	Proceedings of the National Academy of Sciences of the United States of America	2014	30
24568860	Adenosine Triphosphate	Tan W	Role of mitochondria in mutant SOD1 linked amyotrophic lateral sclerosis.	Biochimica et biophysica acta	2014	23
24903093	Adenosine Triphosphate	Bekkering S	Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes.	Arteriosclerosis, thrombosis, and vascular biology	2014	24
25136135	Adenosine Triphosphate	Nguyen TT	Loss of Miro1-directed mitochondrial movement results in a novel murine model for neuron disease.	Proceedings of the National Academy of Sciences of the United States of America	2014	36
25223574	Adenosine Triphosphate	Sperlágh B	P2X7 receptor: an emerging target in central nervous system diseases.	Trends in pharmacological sciences	2014	48
25435018	Adenosine Triphosphate	Silva R	Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy.	Pharmacology & therapeutics	2015	27
26027935	Adenosine Triphosphate	Cullen SP	Diverse Activators of the NLRP3 Inflammasome Promote IL-1β Secretion by Triggering Necrosis.	Cell reports	2015	33
26300264	Adenosine Triphosphate	Gao X	Human Hsp70 Disaggregase Reverses Parkinson's-Linked α-Synuclein Amyloid Fibrils.	Molecular cell	2015	43
26499806	Adenosine Triphosphate	Chen Z	Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade.	Cancer letters	2016	53
26698230	Adenosine Triphosphate	Nitulescu GM	Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review).	International journal of oncology	2016	27
26923599	Adenosine Triphosphate	Rainbolt TK	Reciprocal Degradation of YME1L and OMA1 Adapts Mitochondrial Proteolytic Activity during Stress.	Cell reports	2016	10
27050154	Adenosine Triphosphate	Finka A	Experimental Milestones in the Discovery of Molecular Chaperones as Polypeptide Unfolding Enzymes.	Annual review of biochemistry	2016	12
27693323	Adenosine Triphosphate	Shouval DS	Interleukin 1β Mediates Intestinal Inflammation in Mice and Patients With Interleukin 10 Receptor Deficiency.	Gastroenterology	2016	10
28663500	Adenosine Triphosphate	Adebesin F	Emission of volatile organic compounds from petunia flowers is facilitated by an ABC transporter.	Science	2017	7
12042811	Dopamine	Xu J	Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease.	Nature medicine	2002	150
15502868	Dopamine	Martinat C	Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: an ES- derived cell model of primary Parkinsonism.	PLoS biology	2004	81
15590933	Dopamine	Yavich L	Role of alpha-synuclein in presynaptic dopamine recruitment.	The Journal of neuroscience 	2004	81
15777250	Dopamine	Nagatsu T	Inflammatory process in Parkinson's disease: role for cytokines.	Current pharmaceutical design	2005	72
16227205	Dopamine	Zhou W	DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity.	The Journal of biological chemistry	2005	99
16518646	Dopamine	Johanson CE	Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers.	Psychopharmacology	2006	66
16803859	Dopamine	Urban JD	Functional selectivity and classical concepts of quantitative pharmacology.	The Journal of pharmacology and experimental therapeutics	2007	363
17318414	Dopamine	Swanson JM	Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis.	Neuropsychology review	2007	120
17904601	Dopamine	White LD	New and evolving concepts in the neurotoxicology of lead.	Toxicology and applied pharmacology	2007	75
17992686	Dopamine	McCann UD	Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users.	Synapse	2008	71
19164583	Dopamine	Li Y	GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism.	Proceedings of the National Academy of Sciences of the United States of America	2009	109
19303005	Dopamine	Büeler H	Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.	Experimental neurology	2009	75
20427663	Dopamine	Bowton E	Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder.	The Journal of neuroscience 	2010	45
20534649	Dopamine	Garcia-Reitböck P	SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease.	Brain 	2010	66
21712347	Dopamine	Decressac M	GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease.	Brain 	2011	43
24995986	Dopamine	Rothwell PE	Autism-associated neuroligin-3 mutations commonly impair striatal circuits to boost repetitive behaviors.	Cell	2014	81
25127144	Dopamine	Panman L	Sox6 and Otx2 control the specification of substantia nigra and ventral tegmental area dopamine neurons.	Cell reports	2014	20
25588018	Dopamine	Liechti M	Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling.	Swiss medical weekly	2015	19
26858591	Dopamine	Collier TJ	Is Alpha-Synuclein Loss-of-Function a Contributor to Parkinsonian Pathology? Evidence from Non-human Primates.	Frontiers in neuroscience	2016	15
11150311	Anti-Bacterial Agents	Okamura Y	The extra domain A of fibronectin activates Toll-like receptor 4.	The Journal of biological chemistry	2001	243
22146873	Anti-Bacterial Agents	Hensgens MP	Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics.	The Journal of antimicrobial chemotherapy	2012	41
22980180	Anti-Bacterial Agents	Ruparel NB	Direct effect of intracanal medicaments on survival of stem cells of the apical papilla.	Journal of endodontics	2012	41
24316517	Anti-Bacterial Agents	Vrieze A	Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.	Journal of hepatology	2014	53
24604900	Anti-Bacterial Agents	See I	NAP1 strain type predicts outcomes from Clostridium difficile infection.	Clinical infectious diseases 	2014	25
24696436	Anti-Bacterial Agents	Walker MJ	Disease manifestations and pathogenic mechanisms of Group A Streptococcus.	Clinical microbiology reviews	2014	91
26348734	Anti-Bacterial Agents	Polage CR	Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.	JAMA internal medicine	2015	46
28337021	Anti-Bacterial Agents	Dickey SW	Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance.	Nature reviews. Drug discovery	2017	16
9177350	Cysteine	Pan Y	Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation.	Nature	1997	111
9326641	Cysteine	Bootcov MR	MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily.	Proceedings of the National Academy of Sciences of the United States of America	1997	184
9337844	Cysteine	Cohen GM	Caspases: the executioners of apoptosis.	The Biochemical journal	1997	612
10506580	Cysteine	Duncan MR	Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP.	FASEB journal 	1999	118
10648003	Cysteine	Buechler C	Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli.	Journal of leukocyte biology	2000	137
16790522	Cysteine	Cole JN	Trigger for group A streptococcal M1T1 invasive disease.	FASEB journal 	2006	64
16894167	Cysteine	Meulener MC	Mutational analysis of DJ-1 in Drosophila implicates functional inactivation by oxidative damage and aging.	Proceedings of the National Academy of Sciences of the United States of America	2006	76
19007302	Cysteine	Guo CJ	S-nitrosylation of surfactant protein-D controls inflammatory function.	PLoS biology	2008	53
19273553	Cysteine	Fonseca JM	Instability of a class a G protein-coupled receptor oligomer interface.	Molecular pharmacology	2009	47
19826485	Cysteine	Craven RR	Staphylococcus aureus alpha-hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells.	PloS one	2009	122
19860916	Cysteine	Ryan CL	Progranulin is expressed within motor neurons and promotes neuronal cell survival.	BMC neuroscience	2009	52
20191298	Cysteine	Kimura H	Hydrogen sulfide: its production, release and functions.	Amino acids	2011	105
20421418	Cysteine	Lau A	A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62.	Molecular and cellular biology	2010	177
22158122	Cysteine	Zhang L	Cysteine methylation disrupts ubiquitin-chain sensing in NF-κB activation.	Nature	2011	50
22388478	Cysteine	Shang YC	Prevention of β-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K/mTOR pathway, Bad, and Bcl-xL.	Aging	2012	46
22632748	Cysteine	Vendramini-Costa DB	Molecular link mechanisms between inflammation and cancer.	Current pharmaceutical design	2012	101
24297919	Cysteine	Gilchrist J	Crystallographic insights into sodium-channel modulation by the β4 subunit.	Proceedings of the National Academy of Sciences of the United States of America	2013	35
24331465	Cysteine	Barnett TC	The globally disseminated M1T1 clone of group A Streptococcus evades autophagy for intracellular replication.	Cell host & microbe	2013	29
27650695	Cysteine	Pla D	Proteomics and antivenomics of Papuan black snake (Pseudechis papuanus) venom with analysis of its toxicological profile and the preclinical efficacy of Australian antivenoms.	Journal of proteomics	2017	5
28262504	Cysteine	Dong Z	Mitochondrial Ca2+ Uniporter Is a Mitochondrial Luminal Redox Sensor that Augments MCU Channel Activity.	Molecular cell	2017	14
1346269	Cycloheximide	Groux H	Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals.	The Journal of experimental medicine	1992	183
2065663	Cycloheximide	Schreck R	Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1.	The EMBO journal	1991	519
3096580	Cycloheximide	Sen R	Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism.	Cell	1986	521
9207008	Cycloheximide	Amara A	HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication.	The Journal of experimental medicine	1997	137
10761935	Cycloheximide	Chandrashekar J	T2Rs function as bitter taste receptors.	Cell	2000	249
11238378	Cycloheximide	Sakamoto T	KNOX homeodomain protein directly suppresses the expression of a gibberellin biosynthetic gene in the tobacco shoot apical meristem.	Genes & development	2001	91
11584276	Guanosine Triphosphate	Hussain NK	Endocytic protein intersectin-l regulates actin assembly via Cdc42 and N-WASP.	Nature cell biology	2001	112
12237774	Guanosine Triphosphate	Fritz G	Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters.	British journal of cancer	2002	102
15613346	Guanosine Triphosphate	Naranatt PP	Kaposi's sarcoma-associated herpesvirus modulates microtubule dynamics via RhoA-GTP-diaphanous 2 signaling and utilizes the dynein motors to deliver its DNA to the nucleus.	Journal of virology	2005	79
24759106	Guanosine Triphosphate	Cuadrado A	Transcription factors NRF2 and NF-κB are coordinated effectors of the Rho family, GTP-binding protein RAC1 during inflammation.	The Journal of biological chemistry	2014	27
25517096	Guanosine Triphosphate	Renard HF	Endophilin-A2 functions in membrane scission in clathrin-independent endocytosis.	Nature	2015	52
12202460	Bile Acids and Salts	Chiang JY	Bile acid regulation of gene expression: roles of nuclear hormone receptors.	Endocrine reviews	2002	93
12372848	Bile Acids and Salts	Kliewer SA	The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism.	Endocrine reviews	2002	163
14699511	Bile Acids and Salts	Kullak-Ublick GA	Enterohepatic bile salt transporters in normal physiology and liver disease.	Gastroenterology	2004	88
16749856	Bile Acids and Salts	Zollner G	Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations.	Molecular pharmaceutics	2006	61
17116003	Bile Acids and Salts	Lundåsen T	Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.	Journal of internal medicine	2006	96
17291602	Bile Acids and Salts	Geier A	Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration.	Biochimica et biophysica acta	2007	65
18668430	Bile Acids and Salts	Hagenbuch B	Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family.	Xenobiotica; the fate of foreign compounds in biological systems	2008	90
20103563	Bile Acids and Salts	Klaassen CD	Xenobiotic, bile acid, and cholesterol transporters: function and regulation.	Pharmacological reviews	2010	166
21103971	Bile Acids and Salts	Stieger B	The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.	Handbook of experimental pharmacology	2011	44
21504868	Bile Acids and Salts	Smathers RL	The human fatty acid-binding protein family: evolutionary divergences and functions.	Human genomics	2011	59
21965623	Bile Acids and Salts	Dawson S	In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.	Drug metabolism and disposition	2012	39
22810731	Bile Acids and Salts	Marcinkiewicz J	Taurine and inflammatory diseases.	Amino acids	2014	37
23141891	Bile Acids and Salts	Poupon R	Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action.	Clinics and research in hepatology and gastroenterology	2012	33
23391614	Bile Acids and Salts	Lake AD	Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease.	Toxicology and applied pharmacology	2013	30
23956101	Bile Acids and Salts	Morgan RE	A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.	Toxicological sciences 	2013	28
23982684	Bile Acids and Salts	Schaap FG	Bile acid receptors as targets for drug development.	Nature reviews. Gastroenterology & hepatology	2014	61
24189185	Bile Acids and Salts	Rižner TL	Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism.	Steroids	2014	21
24799086	Bile Acids and Salts	Aleo MD	Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.	Hepatology	2014	25
25073467	Bile Acids and Salts	Li T	Bile acid signaling in metabolic disease and drug therapy.	Pharmacological reviews	2014	72
25584736	Bile Acids and Salts	Li T	Bile acids as metabolic regulators.	Current opinion in gastroenterology	2015	27
25617503	Bile Acids and Salts	Mueller M	Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity.	Journal of hepatology	2015	19
25636263	Bile Acids and Salts	Woolbright BL	Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis.	Toxicology and applied pharmacology	2015	33
26706784	Bile Acids and Salts	Copple BL	Pharmacology of bile acid receptors: Evolution of bile acids from simple detergents to complex signaling molecules.	Pharmacological research	2016	13
26838806	Bile Acids and Salts	Zhang Y	Bcl2 is a critical regulator of bile acid homeostasis by dictating Shp and lncRNA H19 function.	Scientific reports	2016	17
27692610	Bile Acids and Salts	Guo C	Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome.	Immunity	2016	17
3264384	Cyclophosphamide	Rosenberg SA	Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.	The New England journal of medicine	1988	261
15016643	Cyclophosphamide	Pfreundschuh M	Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.	Blood	2004	72
16129365	Cyclophosphamide	Berthold F	Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial.	The Lancet. Oncology	2005	70
16648042	Cyclophosphamide	Pfreundschuh M	CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group.	The Lancet. Oncology	2006	285
18226581	Cyclophosphamide	Pfreundschuh M	Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).	The Lancet. Oncology	2008	154
21087487	Cyclophosphamide	Goldstone JV	Identification and developmental expression of the full complement of Cytochrome P450 genes in Zebrafish.	BMC genomics	2010	57
21690475	Cyclophosphamide	Slingluff CL Jr	Randomized multicenter trial of the effects of melanoma-associated helper peptides and cyclophosphamide on the immunogenicity of a multipeptide melanoma vaccine.	Journal of clinical oncology 	2011	40
22173060	Cyclophosphamide	Trappe R	Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.	The Lancet. Oncology	2012	33
22276820	Cyclophosphamide	von Minckwitz G	Neoadjuvant chemotherapy and bevacizumab for HER2-negative breast cancer.	The New England journal of medicine	2012	104
23578722	Cyclophosphamide	Delarue R	Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial.	The Lancet. Oncology	2013	31
9630891	Doxorubicin	Vaughan TJ	Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library.	Nature biotechnology	1996	137
12203114	Doxorubicin	Budanov AV	Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability.	Oncogene	2002	90
15054096	Doxorubicin	Wang S	Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediacy of H(2)O(2)- and p53-dependent pathways.	The Journal of biological chemistry	2004	97
17875789	Doxorubicin	Stein R	CD74: a new candidate target for the immunotherapy of B-cell neoplasms.	Clinical cancer research 	2007	56
18039953	Doxorubicin	Nefedova Y	Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy.	Blood	2008	54
19839049	Doxorubicin	Tryndyak VP	E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells.	International journal of cancer	2010	62
20442777	Doxorubicin	Bandyopadhyay A	Doxorubicin in combination with a small TGFbeta inhibitor: a potential novel therapy for metastatic breast cancer in mouse models.	PloS one	2010	50
23563091	Doxorubicin	Gao AM	Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402/ADM cells to doxorubicin via inhibiting PI3K/Akt/Nrf2 pathway.	Carcinogenesis	2013	26
24336073	Doxorubicin	Lezina L	miR-16 and miR-26a target checkpoint kinases Wee1 and Chk1 in response to p53 activation by genotoxic stress.	Cell death & disease	2013	28
25330770	Doxorubicin	Liu JC	Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2K.	EMBO molecular medicine	2014	25
25789975	Doxorubicin	Hall JR	Long noncoding RNA lincRNA-p21 is the major mediator of UVB-induced and p53-dependent apoptosis in keratinocytes.	Cell death & disease	2015	16
7569975	Dexamethasone	Scheinman RI	Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids.	Science	1995	204
10935643	Dexamethasone	Xie W	Humanized xenobiotic response in mice expressing nuclear receptor SXR.	Nature	2000	148
22740309	Dexamethasone	Melief J	Phenotyping primary human microglia: tight regulation of LPS responsiveness.	Glia	2012	34
25064128	Dexamethasone	Gibbs J	An epithelial circadian clock controls pulmonary inflammation and glucocorticoid action.	Nature medicine	2014	55
8035341	Carcinogens	Shimada T	Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.	The Journal of pharmacology and experimental therapeutics	1994	232
8674051	Carcinogens	Shimada T	Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1.	Cancer research	1996	112
8832894	Carcinogens	Denissenko MF	Preferential formation of benzoapyrene adducts at lung cancer mutational hotspots in P53.	Science	1996	236
10667461	Carcinogens	Hein DW	Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.	Cancer epidemiology, biomarkers & prevention 	2000	119
23371292	Carcinogens	Zhu AZ	The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: the influence of genetics, race, and sex.	Cancer epidemiology, biomarkers & prevention 	2013	28
16475973	Antineoplastic Agents	Fritz G	Rho GTPases: promising cellular targets for novel anticancer drugs.	Current cancer drug targets	2006	64
18187804	Antineoplastic Agents	Blower PE	MicroRNAs modulate the chemosensitivity of tumor cells.	Molecular cancer therapeutics	2008	97
22234808	Antineoplastic Agents	Hellwig CT	TRAIL signaling and synergy mechanisms used in TRAIL-based combination therapies.	Molecular cancer therapeutics	2012	50
22778315	Antineoplastic Agents	Busaidy NL	Management of metabolic effects associated with anticancer agents targeting the PI3K-Akt-mTOR pathway.	Journal of clinical oncology 	2012	41
23070002	Antineoplastic Agents	Safa AR	c-FLIP, a master anti-apoptotic regulator.	Experimental oncology	2012	58
23674815	Antineoplastic Agents	Clem BF	Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer.	Molecular cancer therapeutics	2013	45
25630663	Antineoplastic Agents	Shrivastava A	Recent developments in L-asparaginase discovery and its potential as anticancer agent.	Critical reviews in oncology/hematology	2016	13
20099276	Cisplatin	Pogribny IP	Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin.	International journal of cancer	2010	94
20530669	Cisplatin	Jiang T	High levels of Nrf2 determine chemoresistance in type II endometrial cancer.	Cancer research	2010	80
21903745	Cisplatin	Curran WJ Jr	Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.	Journal of the National Cancer Institute	2011	174
22431999	Cisplatin	Bruno S	Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury.	PloS one	2012	135
22562073	Cisplatin	Kaminskyy VO	Suppression of basal autophagy reduces lung cancer cell proliferation and enhances caspase-dependent and -independent apoptosis by stimulating ROS formation.	Autophagy	2012	38
24473399	Cisplatin	Kurokawa Y	Phase II study of trastuzumab in combination with S-1 plus cisplatin in HER2-positive gastric cancer (HERBIS-1).	British journal of cancer	2014	26
24552320	Cisplatin	Tewari KS	Improved survival with bevacizumab in advanced cervical cancer.	The New England journal of medicine	2014	164
24989332	Cisplatin	Hassan R	Phase 1 study of the antimesothelin immunotoxin SS1P in combination with pemetrexed and cisplatin for front-line therapy of pleural mesothelioma and correlation of tumor response with serum mesothelin, megakaryocyte potentiating factor, and cancer antigen 125.	Cancer	2014	41
25701171	Cisplatin	Paz-Ares L	Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study.	The Lancet. Oncology	2015	31
26045340	Cisplatin	Thatcher N	Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.	The Lancet. Oncology	2015	69
26719230	Cisplatin	Zalcman G	Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial.	Lancet	2016	63
27055401	Cisplatin	Sakallı Çetin E	Selenium potentiates the anticancer effect of cisplatin against oxidative stress and calcium ion signaling-induced intracellular toxicity in MCF-7 breast cancer cells: involvement of the TRPV1 channel.	Journal of receptor and signal transduction research	2017	5
27270317	Cisplatin	Jiang P	NEAT1 upregulates EGCG-induced CTR1 to enhance cisplatin sensitivity in lung cancer cells.	Oncotarget	2016	16
28163000	Cisplatin	Cunningham D	Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2-3 trial.	The Lancet. Oncology	2017	7
28164431	Cisplatin	Ragni E	Extracellular Vesicle-Shuttled mRNA in Mesenchymal Stem Cell Communication.	Stem cells	2017	6
2161532	Oxygen	Falk RJ	Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro.	Proceedings of the National Academy of Sciences of the United States of America	1990	225
8770536	Oxygen	Hayes JD	The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance.	Critical reviews in biochemistry and molecular biology	1995	479
10631150	Oxygen	Yamada N	Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema.	American journal of human genetics	2000	132
14580780	Oxygen	Waisberg M	Molecular and cellular mechanisms of cadmium carcinogenesis.	Toxicology	2003	138
15073152	Oxygen	Pesah Y	Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress.	Development	2004	133
15170365	Oxygen	Syme MR	Drug transfer and metabolism by the human placenta.	Clinical pharmacokinetics	2004	74
15857155	Oxygen	Thiel M	Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury.	PLoS biology	2005	102
15920011	Oxygen	Chauveau C	Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression.	Blood	2005	93
16446448	Oxygen	Vartanian V	The metabolic syndrome resulting from a knockout of the NEIL1 DNA glycosylase.	Proceedings of the National Academy of Sciences of the United States of America	2006	80
17363476	Oxygen	Valerie K	Radiation-induced cell signaling: inside-out and outside-in.	Molecular cancer therapeutics	2007	115
17401425	Oxygen	Hussain SP	TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.	Oncogene	2007	116
17916722	Oxygen	Semenza GL	Life with oxygen.	Science	2007	169
17967948	Oxygen	Bihlmaier K	The disulfide relay system of mitochondria is connected to the respiratory chain.	The Journal of cell biology	2007	61
17998060	Oxygen	Brown JM	Tumor hypoxia in cancer therapy.	Methods in enzymology	2007	69
18717629	Oxygen	Calkins MJ	The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease.	Antioxidants & redox signaling	2009	97
20015196	Oxygen	Chiche J	Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer.	Journal of cellular and molecular medicine	2010	115
20018894	Oxygen	Takagi S	MicroRNAs regulate human hepatocyte nuclear factor 4alpha, modulating the expression of metabolic enzymes and cell cycle.	The Journal of biological chemistry	2010	48
20718759	Oxygen	Elmarakby AA	Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.	Cardiovascular therapeutics	2012	65
21245297	Oxygen	Hess A	Blockade of TNF-α rapidly inhibits pain responses in the central nervous system.	Proceedings of the National Academy of Sciences of the United States of America	2011	59
21365312	Oxygen	Baird L	The cytoprotective role of the Keap1-Nrf2 pathway.	Archives of toxicology	2011	165
21550379	Oxygen	Jeppesen DK	DNA repair deficiency in neurodegeneration.	Progress in neurobiology	2011	86
21606348	Oxygen	Billia F	PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart function.	Proceedings of the National Academy of Sciences of the United States of America	2011	78
22084410	Oxygen	Swarup V	Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor κB-mediated pathogenic pathways.	The Journal of experimental medicine	2011	61
22281437	Oxygen	Lozy F	Autophagy and cancer cell metabolism.	Seminars in cell & developmental biology	2012	54
22333951	Oxygen	Raju D	Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans.	Gastroenterology	2012	40
23041058	Oxygen	Lee JH	Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression.	Pharmacology & therapeutics	2013	34
23357108	Oxygen	Stenvinkel P	Chronic kidney disease: a clinical model of premature aging.	American journal of kidney diseases 	2013	29
23461806	Oxygen	Corcoran A	Redox regulation of protein kinases.	The FEBS journal	2013	50
24055979	Oxygen	Rao VK	Mitochondrial permeability transition pore is a potential drug target for neurodegeneration.	Biochimica et biophysica acta	2014	30
24318116	Oxygen	Williams AE	The mercurial nature of neutrophils: still an enigma in ARDS?	American journal of physiology. Lung cellular and molecular physiology	2014	52
24695224	Oxygen	Gad H	MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool.	Nature	2014	83
25216678	Oxygen	Durcan TM	USP8 regulates mitophagy by removing K6-linked ubiquitin conjugates from parkin.	The EMBO journal	2014	55
25351418	Oxygen	van den Beucken T	Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER.	Nature communications	2014	43
25535359	Oxygen	Amelio I	TAp73 opposes tumor angiogenesis by promoting hypoxia-inducible factor 1α degradation.	Proceedings of the National Academy of Sciences of the United States of America	2015	26
25583481	Oxygen	Bartesaghi S	Inhibition of oxidative metabolism leads to p53 genetic inactivation and transformation in neural stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2015	15
25661091	Oxygen	Thornton C	Role of mitochondria in apoptotic and necroptotic cell death in the developing brain.	Clinica chimica acta; international journal of clinical chemistry	2015	15
25912479	Oxygen	Schäfer M	Nrf2--A regulator of keratinocyte redox signaling.	Free radical biology & medicine	2015	19
26073944	Oxygen	Mantel CR	Enhancing Hematopoietic Stem Cell Transplantation Efficacy by Mitigating Oxygen Shock.	Cell	2015	32
26568842	Oxygen	Watson AS	Autophagy limits proliferation and glycolytic metabolism in acute myeloid leukemia.	Cell death discovery	2015	22
27967234	Oxygen	Yee M	Alternative Progenitor Lineages Regenerate the Adult Lung Depleted of Alveolar Epithelial Type 2 Cells.	American journal of respiratory cell and molecular biology	2017	5
11331304	Cholesterol	Nichols BJ	Rapid cycling of lipid raft markers between the cell surface and Golgi complex.	The Journal of cell biology	2001	170
12050382	Cholesterol	Liu NQ	Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway.	Journal of virology	2002	80
12070301	Cholesterol	Choudhury A	Rab proteins mediate Golgi transport of caveola-internalized glycosphingolipids and correct lipid trafficking in Niemann-Pick C cells.	The Journal of clinical investigation	2002	147
14764880	Cholesterol	del Pozo MA	Integrins regulate Rac targeting by internalization of membrane domains.	Science	2004	189
15066264	Cholesterol	Guirland C	Lipid rafts mediate chemotropic guidance of nerve growth cones.	Neuron	2004	70
15543155	Cholesterol	Giddings KS	Human CD59 is a receptor for the cholesterol-dependent cytolysin intermedilysin.	Nature structural & molecular biology	2004	76
16127462	Cholesterol	Vikramadithyan RK	Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice.	The Journal of clinical investigation	2005	68
18053320	Cholesterol	Klonoff DC	Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years.	Current medical research and opinion	2008	153
18223541	Cholesterol	Williams KJ	Rapid regression of atherosclerosis: insights from the clinical and experimental literature.	Nature clinical practice. Cardiovascular medicine	2008	70
20178746	Cholesterol	Römer W	Actin dynamics drive membrane reorganization and scission in clathrin-independent endocytosis.	Cell	2010	71
20597103	Cholesterol	Kim MJ	Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism.	EMBO molecular medicine	2010	119
20668705	Cholesterol	Rajamäki K	Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation.	PloS one	2010	164
21220512	Cholesterol	Du X	A role for oxysterol-binding protein-related protein 5 in endosomal cholesterol trafficking.	The Journal of cell biology	2011	56
23206728	Cholesterol	Musso G	Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis.	Progress in lipid research	2013	49
23296339	Cholesterol	Liu CC	Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy.	Nature reviews. Neurology	2013	318
24504735	Cholesterol	Du F	MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice.	Arteriosclerosis, thrombosis, and vascular biology	2014	31
25332099	Cholesterol	Płóciennikowska A	Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling.	Cellular and molecular life sciences 	2015	44
25440714	Cholesterol	Gilbert RJ	Membrane pore formation at protein-lipid interfaces.	Trends in biochemical sciences	2014	34
25871773	Cholesterol	Hu J	Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice.	Molecular neurodegeneration	2015	19
25904599	Cholesterol	Zhang H	Functional analysis and transcriptomic profiling of iPSC-derived macrophages and their application in modeling Mendelian disease.	Circulation research	2015	18
26892966	Cholesterol	Sorci-Thomas MG	Microdomains, Inflammation, and Atherosclerosis.	Circulation research	2016	18
28153991	Cholesterol	Lew J	Sex-Based Differences in Cardiometabolic Biomarkers.	Circulation	2017	7
28336668	Cholesterol	Castellano BM	Lysosomal cholesterol activates mTORC1 via an SLC38A9-Niemann-Pick C1 signaling complex.	Science	2017	17
15057820	Carbamazepine	Chung WH	Medical genetics: a marker for Stevens-Johnson syndrome.	Nature	2004	192
16538176	Carbamazepine	Hung SI	Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions.	Pharmacogenetics and genomics	2006	86
20522742	Carbamazepine	Hidvegi T	An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis.	Science	2010	171
21428768	Carbamazepine	Chen P	Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan.	The New England journal of medicine	2011	90
21428769	Carbamazepine	McCormack M	HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans.	The New England journal of medicine	2011	132
22322005	Carbamazepine	Wei CY	Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome.	The Journal of allergy and clinical immunology	2012	45
23695185	Carbamazepine	Leckband SG	Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and carbamazepine dosing.	Clinical pharmacology and therapeutics	2013	43
24322785	Carbamazepine	Genin E	HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis.	The pharmacogenomics journal	2014	27
27939857	Carbamazepine	Iori V	Blockade of the IL-1R1/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsy.	Neurobiology of disease	2017	10
20458318	Creatinine	Vaidya VS	Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies.	Nature biotechnology	2010	111
11409933	Fatty Acids	Guengerich FP	Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity.	Chemical research in toxicology	2001	215
12496284	Fatty Acids	Briscoe CP	The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids.	The Journal of biological chemistry	2003	179
19442172	Fatty Acids	Cani PD	The role of the gut microbiota in energy metabolism and metabolic disease.	Current pharmaceutical design	2009	149
19782153	Fatty Acids	Schrauwen P	Mitochondrial dysfunction and lipotoxicity.	Biochimica et biophysica acta	2010	47
20110572	Fatty Acids	Schwartz EA	Nutrient modification of the innate immune response: a novel mechanism by which saturated fatty acids greatly amplify monocyte inflammation.	Arteriosclerosis, thrombosis, and vascular biology	2010	46
20538623	Fatty Acids	Yang X	Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver.	Genome research	2010	72
21042023	Fatty Acids	Wree A	Obesity affects the liver - the link between adipocytes and hepatocytes.	Digestion	2011	45
21514287	Fatty Acids	Koek GH	The role of oxidative stress in non-alcoholic steatohepatitis.	Clinica chimica acta; international journal of clinical chemistry	2011	64
21745271	Fatty Acids	Svegliati-Baroni G	Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.	Liver international 	2011	64
21985374	Fatty Acids	Tang Y	Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease.	Clinical and experimental immunology	2011	47
22127648	Fatty Acids	Bosma M	The lipid droplet coat protein perilipin 5 also localizes to muscle mitochondria.	Histochemistry and cell biology	2012	41
22326434	Fatty Acids	Cusi K	Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.	Gastroenterology	2012	130
22700961	Fatty Acids	Liu TF	NAD+-dependent sirtuin 1 and 6 proteins coordinate a switch from glucose to fatty acid oxidation during the acute inflammatory response.	The Journal of biological chemistry	2012	54
23855294	Fatty Acids	Roh YS	Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis.	Journal of gastroenterology and hepatology	2013	55
23980144	Fatty Acids	Benjamin DI	Ether lipid generating enzyme AGPS alters the balance of structural and signaling lipids to fuel cancer pathogenicity.	Proceedings of the National Academy of Sciences of the United States of America	2013	47
24997452	Fatty Acids	Varga ZV	Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy.	Biochimica et biophysica acta	2015	38
25584012	Fatty Acids	Bourgeois EA	Bee venom processes human skin lipids for presentation by CD1a.	The Journal of experimental medicine	2015	26
26101138	Fatty Acids	Iraporda C	Lactate and short chain fatty acids produced by microbial fermentation downregulate proinflammatory responses in intestinal epithelial cells and myeloid cells.	Immunobiology	2015	18
26488817	Fatty Acids	Haghikia A	Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine.	Immunity	2015	52
26971994	Fatty Acids	Robblee MM	Saturated Fatty Acids Engage an IRE1α-Dependent Pathway to Activate the NLRP3 Inflammasome in Myeloid Cells.	Cell reports	2016	13
28041958	Fatty Acids	Oishi Y	SREBP1 Contributes to Resolution of Pro-inflammatory TLR4 Signaling by Reprogramming Fatty Acid Metabolism.	Cell metabolism	2017	13
14580882	Colchicine	Betts MR	Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation.	Journal of immunological methods	2003	512
12496163	Hydrogen Peroxide	Cox GM	Superoxide dismutase influences the virulence of Cryptococcus neoformans by affecting growth within macrophages.	Infection and immunity	2003	86
15689384	Hydrogen Peroxide	Klebanoff SJ	Myeloperoxidase: friend and foe.	Journal of leukocyte biology	2005	391
17105724	Hydrogen Peroxide	Bienert GP	Specific aquaporins facilitate the diffusion of hydrogen peroxide across membranes.	The Journal of biological chemistry	2007	224
20724658	Hydrogen Peroxide	Miller EW	Aquaporin-3 mediates hydrogen peroxide uptake to regulate downstream intracellular signaling.	Proceedings of the National Academy of Sciences of the United States of America	2010	117
21186346	Hydrogen Peroxide	Dickinson BC	Nox2 redox signaling maintains essential cell populations in the brain.	Nature chemical biology	2011	72
21771337	Hydrogen Peroxide	O'Hanlon DE	In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide.	BMC infectious diseases	2011	64
22156198	Hydrogen Peroxide	Pillay J	A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1.	The Journal of clinical investigation	2012	128
24844117	Hydrogen Peroxide	Nauseef WM	Myeloperoxidase in human neutrophil host defence.	Cellular microbiology	2014	27
26096935	Hydrogen Peroxide	Latina A	ΔNp63 targets cytoglobin to inhibit oxidative stress-induced apoptosis in keratinocytes and lung cancer.	Oncogene	2016	12
26706498	Hydrogen Peroxide	Vanhoutte PM	Endothelial dysfunction and vascular disease - a 30th anniversary update.	Acta physiologica	2017	27
27833040	Hydrogen Peroxide	Doskey CM	Tumor cells have decreased ability to metabolize H2O2: Implications for pharmacological ascorbate in cancer therapy.	Redox biology	2016	13
27872049	Hydrogen Peroxide	Nishijima Y	Contribution of KV1.5 Channel to Hydrogen Peroxide-Induced Human Arteriolar Dilation and Its Modulation by Coronary Artery Disease.	Circulation research	2017	8
17884974	Acetaminophen	Hinz B	Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man.	FASEB journal 	2008	57
18818195	Acetaminophen	Porubsky PR	Structures of human cytochrome P-450 2E1. Insights into the binding of inhibitors and both small molecular weight and fatty acid substrates.	The Journal of biological chemistry	2008	52
19416960	Acetaminophen	Harrill AH	Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans.	Genome research	2009	57
20020268	Acetaminophen	Hinson JA	Mechanisms of acetaminophen-induced liver necrosis.	Handbook of experimental pharmacology	2010	131
21745276	Acetaminophen	Jaeschke H	Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity.	Liver international 	2012	88
22229890	Acetaminophen	Jaeschke H	Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity.	Drug metabolism reviews	2012	138
22378043	Acetaminophen	McGill MR	The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation.	The Journal of clinical investigation	2012	139
23223517	Acetaminophen	Hardwick RN	Altered UDP-glucuronosyltransferase and sulfotransferase expression and function during progressive stages of human nonalcoholic fatty liver disease.	Drug metabolism and disposition	2013	25
23462933	Acetaminophen	McGill MR	Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis.	Pharmaceutical research	2013	70
23719833	Acetaminophen	Graham GG	The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.	Inflammopharmacology	2013	37
24118944	Acetaminophen	Thulin P	Keratin-18 and microRNA-122 complement alanine aminotransferase as novel safety biomarkers for drug-induced liver injury in two human cohorts.	Liver international 	2014	21
24440789	Acetaminophen	Williams CD	Neutrophil activation during acetaminophen hepatotoxicity and repair in mice and humans.	Toxicology and applied pharmacology	2014	40
24905542	Acetaminophen	Xie Y	Mechanisms of acetaminophen-induced cell death in primary human hepatocytes.	Toxicology and applied pharmacology	2014	48
25359176	Acetaminophen	Krauskopf J	Application of high-throughput sequencing to circulating microRNAs reveals novel biomarkers for drug-induced liver injury.	Toxicological sciences 	2015	22
25708609	Acetaminophen	Yang X	Potential of extracellular microRNAs as biomarkers of acetaminophen toxicity in children.	Toxicology and applied pharmacology	2015	19
26489516	Acetaminophen	Vliegenthart AD	Comprehensive microRNA profiling in acetaminophen toxicity identifies novel circulating biomarkers for human liver and kidney injury.	Scientific reports	2015	21
26708719	Acetaminophen	Cubero FJ	Combined Activities of JNK1 and JNK2 in Hepatocytes Protect Against Toxic Liver Injury.	Gastroenterology	2016	13
26756674	Acetaminophen	Bhise NS	A liver-on-a-chip platform with bioprinted hepatic spheroids.	Biofabrication	2016	26
27913221	Acetaminophen	Woolbright BL	Role of the inflammasome in acetaminophen-induced liver injury and acute liver failure.	Journal of hepatology	2017	16
16820223	Glutathione	Cole SP	Transport of glutathione and glutathione conjugates by MRP1.	Trends in pharmacological sciences	2006	62
17064675	Glutathione	Park HS	Role of NADPH oxidase 4 in lipopolysaccharide-induced proinflammatory responses by human aortic endothelial cells.	Cardiovascular research	2006	61
18829555	Glutathione	Singh A	RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy.	Cancer research	2008	98
20228251	Glutathione	Lee M	Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases.	FASEB journal 	2010	41
21501670	Glutathione	Rappaport SM	Adductomics: characterizing exposures to reactive electrophiles.	Toxicology letters	2012	40
22375253	Glutathione	Matough FA	The role of oxidative stress and antioxidants in diabetic complications.	Sultan Qaboos University medical journal	2012	36
24186203	Glutathione	Amelio I	p73 regulates serine biosynthesis in cancer.	Oncogene	2014	34
24794031	Glutathione	Brown NC	An updated meta-analysis of oxidative stress markers in bipolar disorder.	Psychiatry research	2014	26
25097261	Glutathione	Salzano S	Linkage of inflammation and oxidative stress via release of glutathionylated peroxiredoxin-2, which acts as a danger signal.	Proceedings of the National Academy of Sciences of the United States of America	2014	45
26578681	Glutathione	Baddal B	Dual RNA-seq of Nontypeable Haemophilus influenzae and Host Cell Transcriptomes Reveals Novel Insights into Host-Pathogen Cross Talk.	mBio	2015	18
28551354	Glutathione	Poprac P	Targeting Free Radicals in Oxidative Stress-Related Human Diseases.	Trends in pharmacological sciences	2017	10
15269313	irinotecan	Cunningham D	Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.	The New England journal of medicine	2004	932
17728214	irinotecan	Hoskins JM	UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters.	Journal of the National Cancer Institute	2007	109
21119032	irinotecan	Moehler M	Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: a prospective multi-center biomarker-oriented phase II study.	Annals of oncology 	2011	36
22203733	irinotecan	Montano R	Preclinical development of the novel Chk1 inhibitor SCH900776 in combination with DNA-damaging agents and antimetabolites.	Molecular cancer therapeutics	2012	53
26101915	irinotecan	Goldenberg DM	Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC).	Oncotarget	2015	17
26615328	irinotecan	Wang-Gillam A	Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial.	Lancet	2016	66
11357875	Paclitaxel	Takeuchi O	Toll-like receptors; their physiological role and signal transduction system.	International immunopharmacology	2001	85
11912497	Paclitaxel	Hajjar AM	Human Toll-like receptor 4 recognizes host-specific LPS modifications.	Nature immunology	2002	144
15241487	Paclitaxel	Domina AM	MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol.	Oncogene	2004	111
16585214	Paclitaxel	Kelly MG	TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer.	Cancer research	2006	135
17440056	Paclitaxel	Alexandre J	Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species.	Cancer research	2007	82
18375893	Paclitaxel	Seidman AD	Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840.	Journal of clinical oncology 	2008	121
19826413	Paclitaxel	Szajnik M	TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer.	Oncogene	2009	55
25154499	Paclitaxel	Wu T	Oxidative stress, mammospheres and Nrf2-new implication for breast cancer therapy?	Molecular carcinogenesis	2015	20
25547504	Paclitaxel	Dang C	Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.	Journal of clinical oncology 	2015	18
28209618	Paclitaxel	Chen MW	The STAT3-miRNA-92-Wnt Signaling Pathway Regulates Spheroid Formation and Malignant Progression in Ovarian Cancer.	Cancer research	2017	7
10430608	Nitric Oxide	Frantz S	Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium.	The Journal of clinical investigation	1999	114
14669979	Nitric Oxide	Kleinert H	Regulation of the expression of inducible nitric oxide synthase.	Biological chemistry	2003	94
14726604	Nitric Oxide	Guzik TJ	Nitric oxide and superoxide in inflammation and immune regulation.	Journal of physiology and pharmacology 	2003	139
15728243	Nitric Oxide	Barshes NR	Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts.	Journal of leukocyte biology	2005	91
15845500	Nitric Oxide	Zughaier SM	Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins.	Infection and immunity	2005	68
15951807	Nitric Oxide	Hara MR	S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding.	Nature cell biology	2005	310
18178554	Nitric Oxide	Liang J	A novel CCCH-zinc finger protein family regulates proinflammatory activation of macrophages.	The Journal of biological chemistry	2008	64
20082095	Nitric Oxide	Michel T	Cellular signaling and NO production.	Pflugers Archiv 	2010	53
22496842	Nitric Oxide	Kim B	Impaired inflammatory responses in murine Lrrk2-knockdown brain microglia.	PloS one	2012	49
23264591	Nitric Oxide	Schaer DJ	Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins.	Blood	2013	115
23473037	Nitric Oxide	Biason-Lauber A	Identification of a SIRT1 mutation in a family with type 1 diabetes.	Cell metabolism	2013	28
24418464	Nitric Oxide	Pieper C	Brain capillary pericytes contribute to the immune defense in response to cytokines or LPS in vitro.	Brain research	2014	27
25384799	Nitric Oxide	Mesci P	System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.	Brain 	2015	16
25884116	Nitric Oxide	Weidinger A	Biological Activities of Reactive Oxygen and Nitrogen Species: Oxidative Stress versus Signal Transduction.	Biomolecules	2015	28
25981191	Nitric Oxide	Krug N	Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme.	The New England journal of medicine	2015	35
26732588	Nitric Oxide	Kallaur AP	Genetic, Immune-Inflammatory, and Oxidative Stress Biomarkers as Predictors for Disability and Disease Progression in Multiple Sclerosis.	Molecular neurobiology	2017	8
26871664	Nitric Oxide	Ince C	THE ENDOTHELIUM IN SEPSIS.	Shock	2016	19
27301879	Nitric Oxide	Thiele Orberg E	The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis.	Mucosal immunology	2017	7
27514990	Nitric Oxide	Balez R	Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer's disease.	Scientific reports	2016	11
27732846	Nitric Oxide	Van den Bossche J	Mitochondrial Dysfunction Prevents Repolarization of Inflammatory Macrophages.	Cell reports	2016	20
15124023	Oligonucleotides, Antisense	Jia SH	Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis.	The Journal of clinical investigation	2004	130
21285523	Oligonucleotides, Antisense	Sah DW	Oligonucleotide therapeutic approaches for Huntington disease.	The Journal of clinical investigation	2011	41
21971427	Oligonucleotides, Antisense	Carroll JB	Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene / allele-specific silencing of mutant huntingtin.	Molecular therapy 	2011	73
24139042	Oligonucleotides, Antisense	Donnelly CJ	RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention.	Neuron	2013	202
24154603	Oligonucleotides, Antisense	Sareen D	Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion.	Science translational medicine	2013	168
27507699	Oligonucleotides, Antisense	van Zundert B	Silencing strategies for therapy of SOD1-mediated ALS.	Neuroscience letters	2017	8
12052830	Phosphatidylinositols	Guha M	The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells.	The Journal of biological chemistry	2002	200
12566441	Phosphatidylinositols	Fujino H	Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases.	The Journal of biological chemistry	2003	77
12620891	Phosphatidylinositols	Park JS	Activation of gene expression in human neutrophils by high mobility group box 1 protein.	American journal of physiology. Cell physiology	2003	105
12925680	Phosphatidylinositols	Vergne I	Tuberculosis toxin blocking phagosome maturation inhibits a novel Ca2+/calmodulin-PI3K hVPS34 cascade.	The Journal of experimental medicine	2003	82
14607241	Phosphatidylinositols	Regan JW	EP2 and EP4 prostanoid receptor signaling.	Life sciences	2003	121
15579900	Phosphatidylinositols	Guillot L	Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus.	The Journal of biological chemistry	2005	193
19318560	Phosphatidylinositols	Szczepanski MJ	Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack.	Cancer research	2009	64
21820214	Phosphatidylinositols	Xu J	Extracellular progranulin protects cortical neurons from toxic insults by activating survival signaling.	Neurobiology of aging	2011	38
21951552	Phosphatidylinositols	Debaisieux S	The ins and outs of HIV-1 Tat.	Traffic	2012	55
22880008	Phosphatidylinositols	Huang WC	Classical macrophage activation up-regulates several matrix metalloproteinases through mitogen activated protein kinases and nuclear factor-κB.	PloS one	2012	31
7822316	Sirolimus	Sabers CJ	Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells.	The Journal of biological chemistry	1995	184
18848473	Sirolimus	Weichhart T	The TSC-mTOR signaling pathway regulates the innate inflammatory response.	Immunity	2008	197
18924132	Sirolimus	Schmitz F	Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells.	European journal of immunology	2008	55
20089925	Sirolimus	Malagelada C	Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease.	The Journal of neuroscience 	2010	107
20335217	Sirolimus	Turnquist HR	mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS.	Blood	2010	47
20371474	Sirolimus	Amin DN	Resiliency and vulnerability in the HER2-HER3 tumorigenic driver.	Science translational medicine	2010	69
20671809	Sirolimus	Martelli AM	The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients.	Oncotarget	2010	76
21472771	Sirolimus	Cullen V	Acid β-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter α-synuclein processing.	Annals of neurology	2011	89
22287548	Sirolimus	Chen W	Macrophage-induced tumor angiogenesis is regulated by the TSC2-mTOR pathway.	Cancer research	2012	37
22817723	Sirolimus	O'Neill C	Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease.	Biochemical Society transactions	2012	38
22895726	Sirolimus	Weston MC	Multiple roles for mammalian target of rapamycin signaling in both glutamatergic and GABAergic synaptic transmission.	The Journal of neuroscience 	2012	36
22919032	Sirolimus	McInturff AM	Mammalian target of rapamycin regulates neutrophil extracellular trap formation via induction of hypoxia-inducible factor 1 α.	Blood	2012	50
22924465	Sirolimus	Maiese K	Targeting disease through novel pathways of apoptosis and autophagy.	Expert opinion on therapeutic targets	2012	48
23902785	Sirolimus	Op den Kamp CM	Nuclear transcription factor κ B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia.	The American journal of clinical nutrition	2013	27
24897931	Sirolimus	Martini M	PI3K/AKT signaling pathway and cancer: an updated review.	Annals of medicine	2014	98
25173700	Sirolimus	Heras-Sandoval D	The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration.	Cellular signalling	2014	95
25940091	Sirolimus	Fonseca BD	La-related Protein 1 (LARP1) Represses Terminal Oligopyrimidine (TOP) mRNA Translation Downstream of mTOR Complex 1 (mTORC1).	The Journal of biological chemistry	2015	26
26917778	Sirolimus	Yun S	4EBP1/c-MYC/PUMA and NF-κB/EGR1/BIM pathways underlie cytotoxicity of mTOR dual inhibitors in malignant lymphoid cells.	Blood	2016	12
28094770	Sirolimus	Martin AR	Rapamycin-mediated mTOR inhibition uncouples HIV-1 latency reversal from cytokine-associated toxicity.	The Journal of clinical investigation	2017	9
28294596	Sirolimus	Bieri R	The Macrolide Toxin Mycolactone Promotes Bim-Dependent Apoptosis in Buruli Ulcer through Inhibition of mTOR.	ACS chemical biology	2017	6
8446170	Superoxides	Rosen DR	Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.	Nature	1993	985
10195180	Superoxides	Williamson TL	Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons.	Nature neuroscience	1999	124
14982937	Superoxides	Bánfi B	Mechanism of Ca2+ activation of the NADPH oxidase 5 (NOX5).	The Journal of biological chemistry	2004	84
16081203	Superoxides	Block ML	Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism.	Progress in neurobiology	2005	315
16953112	Superoxides	Kim YS	Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease.	Experimental & molecular medicine	2006	112
17403682	Superoxides	Zhang F	Interaction between familial amyotrophic lateral sclerosis (ALS)-linked SOD1 mutants and the dynein complex.	The Journal of biological chemistry	2007	55
17435755	Superoxides	Nagai M	Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons.	Nature neuroscience	2007	368
18666828	Superoxides	Wang Q	Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival.	PLoS biology	2008	56
19672969	Superoxides	Zhao W	Extracellular mutant SOD1 induces microglial-mediated motoneuron injury.	Glia	2010	65
20953194	Superoxides	Bosco DA	Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS.	Nature neuroscience	2010	191
21195356	Superoxides	McCombe PA	Effects of gender in amyotrophic lateral sclerosis.	Gender medicine	2010	42
21596768	Superoxides	Beers DR	Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis.	Brain 	2011	83
21813273	Superoxides	Da Cruz S	Understanding the role of TDP-43 and FUS/TLS in ALS and beyond.	Current opinion in neurobiology	2011	122
21832997	Superoxides	Haidet-Phillips AM	Astrocytes from familial and sporadic ALS patients are toxic to motor neurons.	Nature biotechnology	2011	194
22416121	Superoxides	Guareschi S	An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1.	Proceedings of the National Academy of Sciences of the United States of America	2012	58
22431618	Superoxides	Brotherton TE	Localization of a toxic form of superoxide dismutase 1 protein to pathologically affected tissues in familial ALS.	Proceedings of the National Academy of Sciences of the United States of America	2012	34
22967507	Superoxides	Weisberg SJ	Compartmentalization of superoxide dismutase 1 (SOD1G93A) aggregates determines their toxicity.	Proceedings of the National Academy of Sciences of the United States of America	2012	38
23687121	Superoxides	Saccon RA	Is SOD1 loss of function involved in amyotrophic lateral sclerosis?	Brain 	2013	36
24379375	Superoxides	Meyer K	Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS.	Proceedings of the National Academy of Sciences of the United States of America	2014	71
24379756	Superoxides	Rotunno MS	An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis.	Frontiers in cellular neuroscience	2013	40
25411487	Superoxides	Thomsen GM	Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.	The Journal of neuroscience 	2014	24
12239255	Dust	Braun-Fahrländer C	Environmental exposure to endotoxin and its relation to asthma in school-age children.	The New England journal of medicine	2002	273
20391112	Dust	Poole JA	Muramic acid, endotoxin, 3-hydroxy fatty acids, and ergosterol content explain monocyte and epithelial cell inflammatory responses to agricultural dusts.	Journal of toxicology and environmental health. Part A	2010	43
26339029	Dust	Schuijs MJ	Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells.	Science	2015	57
27518660	Dust	Stein MM	Innate Immunity and Asthma Risk in Amish and Hutterite Farm Children.	The New England journal of medicine	2016	42
8497253	Antioxidants	Beg AA	Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation.	Molecular and cellular biology	1993	248
10517533	Antioxidants	Hayes JD	Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress.	Free radical research	1999	217
10562656	Antioxidants	Winkler BS	Oxidative damage and age-related macular degeneration.	Molecular vision	1999	144
10863535	Antioxidants	Gutteridge JM	Free radicals and antioxidants in the year 2000. A historical look to the future.	Annals of the New York Academy of Sciences	2000	109
11060493	Antioxidants	Reiter RJ	Actions of melatonin in the reduction of oxidative stress. A review.	Journal of biomedical science	2000	104
11171943	Antioxidants	Cuzzocrea S	Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury.	Pharmacological reviews	2001	132
12606496	Antioxidants	Robertson RP	Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection.	Diabetes	2003	133
12708612	Antioxidants	Weber LW	Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model.	Critical reviews in toxicology	2003	208
12716823	Antioxidants	Ceriello A	New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy.	Diabetes care	2003	121
12821280	Antioxidants	Ichihashi M	UV-induced skin damage.	Toxicology	2003	101
12821281	Antioxidants	Urso ML	Oxidative stress, exercise, and antioxidant supplementation.	Toxicology	2003	101
15051313	Antioxidants	Cadenas E	Mitochondrial free radical production and cell signaling.	Molecular aspects of medicine	2004	76
15670573	Antioxidants	Costa LG	Modulation of paraoxonase (PON1) activity.	Biochemical pharmacology	2005	70
15985529	Antioxidants	Lee JM	Nrf2, a multi-organ protector?	FASEB journal 	2005	116
17360480	Antioxidants	Zhang WJ	Alpha-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway.	Proceedings of the National Academy of Sciences of the United States of America	2007	68
17636022	Antioxidants	Sun Z	Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2.	Molecular and cellular biology	2007	80
18324353	Antioxidants	Hatcher H	Curcumin: from ancient medicine to current clinical trials.	Cellular and molecular life sciences 	2008	250
18461048	Antioxidants	Förstermann U	Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies.	Nature clinical practice. Cardiovascular medicine	2008	88
19017641	Antioxidants	Lewerenz J	Basal levels of eIF2alpha phosphorylation determine cellular antioxidant status by regulating ATF4 and xCT expression.	The Journal of biological chemistry	2009	54
19273602	Antioxidants	Sun Z	Acetylation of Nrf2 by p300/CBP augments promoter-specific DNA binding of Nrf2 during the antioxidant response.	Molecular and cellular biology	2009	77
19668370	Antioxidants	Sun Z	Phosphorylation of Nrf2 at multiple sites by MAP kinases has a limited contribution in modulating the Nrf2-dependent antioxidant response.	PloS one	2009	55
19716833	Antioxidants	Zhang Q	A systems biology perspective on Nrf2-mediated antioxidant response.	Toxicology and applied pharmacology	2010	42
20231449	Antioxidants	Polyak SJ	Identification of hepatoprotective flavonolignans from silymarin.	Proceedings of the National Academy of Sciences of the United States of America	2010	52
20486766	Antioxidants	Villeneuve NF	Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases.	Antioxidants & redox signaling	2010	81
20805291	Antioxidants	Hardwick RN	Diversity in antioxidant response enzymes in progressive stages of human nonalcoholic fatty liver disease.	Drug metabolism and disposition	2010	54
20972369	Antioxidants	Bouayed J	Exogenous antioxidants--Double-edged swords in cellular redox state: Health beneficial effects at physiologic doses versus deleterious effects at high doses.	Oxidative medicine and cellular longevity	2010	76
21093416	Antioxidants	Costa LG	Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on.	Biochemical pharmacology	2011	35
21294650	Antioxidants	Carrano A	Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy.	Antioxidants & redox signaling	2011	51
21441382	Antioxidants	Lee SJ	Carbon monoxide activates autophagy via mitochondrial reactive oxygen species formation.	American journal of respiratory cell and molecular biology	2011	45
22138445	Antioxidants	Backos DS	The role of glutathione in brain tumor drug resistance.	Biochemical pharmacology	2012	31
22459037	Antioxidants	Jaeschke H	Current strategies to minimize hepatic ischemia-reperfusion injury by targeting reactive oxygen species.	Transplantation reviews	2012	53
22843705	Antioxidants	Kröller-Schön S	Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition.	Cardiovascular research	2012	42
23201771	Antioxidants	Brigelius-Flohé R	Glutathione peroxidases.	Biochimica et biophysica acta	2013	137
23294312	Antioxidants	Ma Q	Role of nrf2 in oxidative stress and toxicity.	Annual review of pharmacology and toxicology	2013	293
23702245	Antioxidants	Dodson M	Cellular metabolic and autophagic pathways: traffic control by redox signaling.	Free radical biology & medicine	2013	81
24036104	Antioxidants	Koskenkorva-Frank TS	The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: insights into the potential of various iron therapies to induce oxidative and nitrosative stress.	Free radical biology & medicine	2013	46
24252614	Antioxidants	Gan X	Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cell.	Biochimica et biophysica acta	2014	42
24798211	Antioxidants	Piechota-Polanczyk A	Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases.	Naunyn-Schmiedeberg's archives of pharmacology	2014	30
24928512	Antioxidants	Ge X	High mobility group box-1 (HMGB1) participates in the pathogenesis of alcoholic liver disease (ALD).	The Journal of biological chemistry	2014	31
25060102	Antioxidants	Zhang HM	Melatonin: a well-documented antioxidant with conditional pro-oxidant actions.	Journal of pineal research	2014	59
25576182	Antioxidants	Ruszkiewicz J	Changes in the mitochondrial antioxidant systems in neurodegenerative diseases and acute brain disorders.	Neurochemistry international	2015	19
25590811	Antioxidants	Singer E	Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma.	Cell death & disease	2015	18
25985305	Antioxidants	Checconi P	Redox proteomics of the inflammatory secretome identifies a common set of redoxins and other glutathionylated proteins released in inflammation, influenza virus infection and oxidative stress.	PloS one	2015	15
26024535	Antioxidants	Deng R	Oxidative stress markers induced by hyperosmolarity in primary human corneal epithelial cells.	PloS one	2015	17
26272235	Antioxidants	Manchester LC	Melatonin: an ancient molecule that makes oxygen metabolically tolerable.	Journal of pineal research	2015	76
26823952	Antioxidants	Sallam N	Exercise Modulates Oxidative Stress and Inflammation in Aging and Cardiovascular Diseases.	Oxidative medicine and cellular longevity	2016	20
9929039	Anti-Inflammatory Agents, Non-Steroidal	Hawkey CJ	COX-2 inhibitors.	Lancet	1999	109
10979111	Anti-Inflammatory Agents, Non-Steroidal	Silverstein FE	Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.	JAMA	2000	304
18851701	Anti-Inflammatory Agents, Non-Steroidal	Marnett LJ	The COXIB experience: a look in the rearview mirror.	Annual review of pharmacology and toxicology	2009	62
21980265	Anti-Inflammatory Agents, Non-Steroidal	McGettigan P	Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies.	PLoS medicine	2011	74
24311630	Anti-Inflammatory Agents, Non-Steroidal	Gurpinar E	NSAIDs inhibit tumorigenesis, but how?	Clinical cancer research 	2014	34
15032591	Adenosine	Buckley RH	Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution.	Annual review of immunology	2004	107
15782185	Adenosine	Hoffmann C	A FlAsH-based FRET approach to determine G protein-coupled receptor activation in living cells.	Nature methods	2005	114
19525944	Adenosine	Orr AG	Adenosine A(2A) receptor mediates microglial process retraction.	Nature neuroscience	2009	75
21734253	Adenosine	Bachmann V	Functional ADA polymorphism increases sleep depth and reduces vigilant attention in humans.	Cerebral cortex	2012	34
21860458	Adenosine	Xiang Y	Using personal glucose meters and functional DNA sensors to quantify a variety of analytical targets.	Nature chemistry	2011	56
22745436	Adenosine	Denmeade SR	Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy.	Science translational medicine	2012	38
23248274	Adenosine	Hikida T	Pathway-specific modulation of nucleus accumbens in reward and aversive behavior via selective transmitter receptors.	Proceedings of the National Academy of Sciences of the United States of America	2013	31
23483055	Adenosine	Desmet CJ	Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis.	Proceedings of the National Academy of Sciences of the United States of America	2013	43
23648170	Adenosine	Lehtiö L	Tankyrases as drug targets.	The FEBS journal	2013	38
25317558	Adenosine	Gnad T	Adenosine activates brown adipose tissue and recruits beige adipocytes via A2A receptors.	Nature	2014	42
19139112	gemcitabine	Parsels LA	Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells.	Molecular cancer therapeutics	2009	51
21208101	gemcitabine	O'Shaughnessy J	Iniparib plus chemotherapy in metastatic triple-negative breast cancer.	The New England journal of medicine	2011	196
21525939	gemcitabine	Donadelli M	Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism.	Cell death & disease	2011	45
21783417	gemcitabine	Zhou C	Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study.	The Lancet. Oncology	2011	839
22276821	gemcitabine	Bear HD	Bevacizumab added to neoadjuvant chemotherapy for breast cancer.	The New England journal of medicine	2012	104
23593991	gemcitabine	Thompson R	The cancer therapeutic potential of Chk1 inhibitors: how mechanistic studies impact on clinical trial design.	British journal of clinical pharmacology	2013	35
24439929	gemcitabine	Wu YL	Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial.	The Lancet. Oncology	2014	282
24954781	gemcitabine	Middleton G	Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial.	The Lancet. Oncology	2014	52
26179201	gemcitabine	Valle JW	Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial.	The Lancet. Oncology	2015	23
26517239	gemcitabine	Vendetti FP	The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo.	Oncotarget	2015	26
27669441	gemcitabine	Richards KE	Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells.	Oncogene	2017	28
9560228	Reactive Oxygen Species	Ramana CV	Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals.	Proceedings of the National Academy of Sciences of the United States of America	1998	100
9633809	Reactive Oxygen Species	Hall ED	Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS.	Glia	1998	124
11402028	Reactive Oxygen Species	Sanlioglu S	Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B.	The Journal of biological chemistry	2001	97
11679166	Reactive Oxygen Species	Forman HJ	Redox signaling in macrophages.	Molecular aspects of medicine	2001	91
14744246	Reactive Oxygen Species	Klaunig JE	The role of oxidative stress in carcinogenesis.	Annual review of pharmacology and toxicology	2004	257
15356101	Reactive Oxygen Species	Park HS	Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B.	Journal of immunology	2004	161
15811878	Reactive Oxygen Species	Komarova EA	p53 is a suppressor of inflammatory response in mice.	FASEB journal 	2005	70
16723122	Reactive Oxygen Species	Gloire G	NF-kappaB activation by reactive oxygen species: fifteen years later.	Biochemical pharmacology	2006	296
17141434	Reactive Oxygen Species	Pulskamp K	Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants.	Toxicology letters	2007	108
17237240	Reactive Oxygen Species	Zhang DX	Mitochondrial reactive oxygen species-mediated signaling in endothelial cells.	American journal of physiology. Heart and circulatory physiology	2007	107
18275858	Reactive Oxygen Species	Liu B	ROS and p53: a versatile partnership.	Free radical biology & medicine	2008	145
19023330	Reactive Oxygen Species	Moisoi N	Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response.	Cell death and differentiation	2009	47
19114105	Reactive Oxygen Species	Semenza GL	Regulation of cancer cell metabolism by hypoxia-inducible factor 1.	Seminars in cancer biology	2009	132
19236887	Reactive Oxygen Species	Liu J	Role of oxidative stress in cadmium toxicity and carcinogenesis.	Toxicology and applied pharmacology	2009	71
19398236	Reactive Oxygen Species	Mandrekar P	Signalling pathways in alcohol-induced liver inflammation.	Journal of hepatology	2009	115
19447517	Reactive Oxygen Species	Baffy G	Kupffer cells in non-alcoholic fatty liver disease: the emerging view.	Journal of hepatology	2009	107
19477268	Reactive Oxygen Species	Miao L	Regulation of superoxide dismutase genes: implications in disease.	Free radical biology & medicine	2009	110
19789524	Reactive Oxygen Species	Misra MK	Oxidative stress and ischemic myocardial syndromes.	Medical science monitor 	2009	66
20689558	Reactive Oxygen Species	Tobaben S	Bid-mediated mitochondrial damage is a key mechanism in glutamate-induced oxidative stress and AIF-dependent cell death in immortalized HT-22 hippocampal neurons.	Cell death and differentiation	2011	41
20880500	Reactive Oxygen Species	Lull ME	Microglial activation and chronic neurodegeneration.	Neurotherapeutics 	2010	124
21901509	Reactive Oxygen Species	Mehri S	Neuroprotective effect of crocin on acrylamide-induced cytotoxicity in PC12 cells.	Cellular and molecular neurobiology	2012	32
22081859	Reactive Oxygen Species	He X	Multiwalled carbon nanotubes induce a fibrogenic response by stimulating reactive oxygen species production, activating NF-κB signaling, and promoting fibroblast-to-myofibroblast transformation.	Chemical research in toxicology	2011	47
22286106	Reactive Oxygen Species	Ray PD	Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling.	Cellular signalling	2012	451
22442078	Reactive Oxygen Species	Misko AL	Mitofusin2 mutations disrupt axonal mitochondrial positioning and promote axon degeneration.	The Journal of neuroscience 	2012	39
22581365	Reactive Oxygen Species	Surace MJ	Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors.	Cellular and molecular life sciences 	2012	32
23311665	Reactive Oxygen Species	Brüne B	Redox control of inflammation in macrophages.	Antioxidants & redox signaling	2013	56
23492768	Reactive Oxygen Species	Wang K	Redox homeostasis: the linchpin in stem cell self-renewal and differentiation.	Cell death & disease	2013	53
23516523	Reactive Oxygen Species	Xie W	MiR-181a regulates inflammation responses in monocytes and macrophages.	PloS one	2013	34
23688501	Reactive Oxygen Species	Sid B	Role of AMPK activation in oxidative cell damage: Implications for alcohol-induced liver disease.	Biochemical pharmacology	2013	31
23977231	Reactive Oxygen Species	Simard JC	S100A8 and S100A9 induce cytokine expression and regulate the NLRP3 inflammasome via ROS-dependent activation of NF-κB(1.).	PloS one	2013	41
24040957	Reactive Oxygen Species	Paik YH	Role of NADPH oxidases in liver fibrosis.	Antioxidants & redox signaling	2014	43
24636985	Reactive Oxygen Species	Wu T	Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis.	Genes & development	2014	44
24779584	Reactive Oxygen Species	Hazeldine J	Impaired neutrophil extracellular trap formation: a novel defect in the innate immune system of aged individuals.	Aging cell	2014	28
25253673	Reactive Oxygen Species	Ebert AD	Characterization of the molecular mechanisms underlying increased ischemic damage in the aldehyde dehydrogenase 2 genetic polymorphism using a human induced pluripotent stem cell model system.	Science translational medicine	2014	27
25330206	Reactive Oxygen Species	Abais JM	Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector?	Antioxidants & redox signaling	2015	42
25341036	Reactive Oxygen Species	Huang H	Mcl-1 promotes lung cancer cell migration by directly interacting with VDAC to increase mitochondrial Ca2+ uptake and reactive oxygen species generation.	Cell death & disease	2014	23
25538153	Reactive Oxygen Species	Planavila A	Fibroblast growth factor 21 protects the heart from oxidative stress.	Cardiovascular research	2015	29
25651975	Reactive Oxygen Species	Hart PC	MnSOD upregulation sustains the Warburg effect via mitochondrial ROS and AMPK-dependent signalling in cancer.	Nature communications	2015	36
25782072	Reactive Oxygen Species	Zeng H	High-fat diet induces cardiac remodelling and dysfunction: assessment of the role played by SIRT3 loss.	Journal of cellular and molecular medicine	2015	17
26627594	Reactive Oxygen Species	Qian P	The Dlk1-Gtl2 Locus Preserves LT-HSC Function by Inhibiting the PI3K-mTOR Pathway to Restrict Mitochondrial Metabolism.	Cell stem cell	2016	19
26825389	Reactive Oxygen Species	Rasheed MZ	Mitochondrial permeability transition pore: a promising target for the treatment of Parkinson's disease.	Protoplasma	2017	8
8599934	Cyclic AMP	Lang P	Protein kinase A phosphorylation of RhoA mediates the morphological and functional effects of cyclic AMP in cytotoxic lymphocytes.	The EMBO journal	1996	125
11773440	Cyclic AMP	Filardo EJ	Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.	Molecular endocrinology	2002	228
12552097	Cyclic AMP	Baillie GS	beta-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi.	Proceedings of the National Academy of Sciences of the United States of America	2003	112
15521361	Cyclic AMP	Neve KA	Dopamine receptor signaling.	Journal of receptor and signal transduction research	2004	207
16966319	Cyclic AMP	Wang J	Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84.	The Journal of biological chemistry	2006	72
18604457	Cyclic AMP	Cheng X	Epac and PKA: a tale of two intracellular cAMP receptors.	Acta biochimica et biophysica Sinica	2008	97
19050283	Cyclic AMP	Sag D	Adenosine 5'-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype.	Journal of immunology	2008	167
22266942	Cyclic AMP	Engel P	Adenylylation control by intra- or intermolecular active-site obstruction in Fic proteins.	Nature	2012	48
22301916	Cyclic AMP	Pimenta de Castro I	Genetic analysis of mitochondrial protein misfolding in Drosophila melanogaster.	Cell death and differentiation	2012	44
24768298	Cyclic AMP	Luan B	Leptin-mediated increases in catecholamine signaling reduce adipose tissue inflammation via activation of macrophage HDAC4.	Cell metabolism	2014	30
25917098	Cyclic AMP	Sokolowska M	Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human Macrophages.	Journal of immunology	2015	25
9204917	Colforsin	Glass M	Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor.	The Journal of neuroscience 	1997	121
23690594	Colforsin	Meyer RC	GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin.	Proceedings of the National Academy of Sciences of the United States of America	2013	33
11520792	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	Guha M	Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression.	Blood	2001	99
16533170	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	Frede S	Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-kappaB.	The Biochemical journal	2006	87
19561104	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	Mandrekar P	The opposite effects of acute and chronic alcohol on lipopolysaccharide-induced inflammation are linked to IRAK-M in human monocytes.	Journal of immunology	2009	69
21123455	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	Lo CW	IL-6 trans-signaling in formation and progression of malignant ascites in ovarian cancer.	Cancer research	2011	42
10572077	wortmannin	Burger JA	Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells.	Blood	1999	113
11706038	wortmannin	Fujino H	Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2.	The Journal of biological chemistry	2002	90
17353198	wortmannin	Ji Z	Oncogenic KRAS activates hedgehog signaling pathway in pancreatic cancer cells.	The Journal of biological chemistry	2007	101
19380828	wortmannin	Oh YJ	HMGB1 is phosphorylated by classical protein kinase C and is secreted by a calcium-dependent mechanism.	Journal of immunology	2009	48
22239975	wortmannin	Ngkelo A	LPS induced inflammatory responses in human peripheral blood mononuclear cells is mediated through NOX4 and Giα dependent PI-3kinase signalling.	Journal of inflammation	2012	34
22045765	fludarabine	Sorror ML	Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies.	JAMA	2011	48
22873532	fludarabine	Kluin-Nelemans HC	Treatment of older patients with mantle-cell lymphoma.	The New England journal of medicine	2012	58
24719405	fludarabine	Bachanova V	Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein.	Blood	2014	71
26492934	fludarabine	Thompson PA	Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia.	Blood	2016	29
26639348	fludarabine	Roberts AW	Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia.	The New England journal of medicine	2016	143
28395880	fludarabine	Chandran SS	Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study.	The Lancet. Oncology	2017	8
10078548	Islet Amyloid Polypeptide	Janson J	The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles.	Diabetes	1999	156
12234175	Islet Amyloid Polypeptide	Anguiano M	Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes.	Biochemistry	2002	84
18989932	Islet Amyloid Polypeptide	Nanga RP	Structures of rat and human islet amyloid polypeptide IAPP(1-19) in micelles by NMR spectroscopy.	Biochemistry	2008	56
19244249	Islet Amyloid Polypeptide	Patil SM	Dynamic alpha-helix structure of micelle-bound human amylin.	The Journal of biological chemistry	2009	53
19346479	Islet Amyloid Polypeptide	Shim SH	Two-dimensional IR spectroscopy and isotope labeling defines the pathway of amyloid formation with residue-specific resolution.	Proceedings of the National Academy of Sciences of the United States of America	2009	93
20042670	Islet Amyloid Polypeptide	Gurlo T	Evidence for proteotoxicity in beta cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway.	The American journal of pathology	2010	65
20160085	Islet Amyloid Polypeptide	Potter KJ	Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts.	Proceedings of the National Academy of Sciences of the United States of America	2010	57
21742788	Islet Amyloid Polypeptide	Westermark P	Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.	Physiological reviews	2011	174
21942864	Islet Amyloid Polypeptide	Brender JR	Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective.	Accounts of chemical research	2012	71
23337872	Islet Amyloid Polypeptide	Abedini A	Mechanisms of islet amyloidosis toxicity in type 2 diabetes.	FEBS letters	2013	32
24589570	Islet Amyloid Polypeptide	Bram Y	Apoptosis induced by islet amyloid polypeptide soluble oligomers is neutralized by diabetes-associated specific antibodies.	Scientific reports	2014	24
25036706	Islet Amyloid Polypeptide	Shigihara N	Human IAPP-induced pancreatic β cell toxicity and its regulation by autophagy.	The Journal of clinical investigation	2014	30
25149184	Islet Amyloid Polypeptide	Srodulski S	Neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of amylin.	Molecular neurodegeneration	2014	25
25998900	Islet Amyloid Polypeptide	Mukherjee A	Type 2 diabetes as a protein misfolding disease.	Trends in molecular medicine	2015	25
10958659	polyglutamine	McCampbell A	CREB-binding protein sequestration by expanded polyglutamine.	Human molecular genetics	2000	109
12651870	polyglutamine	Taylor JP	Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein.	Human molecular genetics	2003	119
12747895	polyglutamine	Bates G	Huntingtin aggregation and toxicity in Huntington's disease.	Lancet	2003	106
15036808	polyglutamine	Li SH	Huntingtin-protein interactions and the pathogenesis of Huntington's disease.	Trends in genetics 	2004	137
15483602	polyglutamine	Arrasate M	Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death.	Nature	2004	553
15811941	polyglutamine	Harper SQ	RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model.	Proceedings of the National Academy of Sciences of the United States of America	2005	195
16141322	polyglutamine	Iwata A	Increased susceptibility of cytoplasmic over nuclear polyglutamine aggregates to autophagic degradation.	Proceedings of the National Academy of Sciences of the United States of America	2005	96
16804541	polyglutamine	Moseley ML	Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8.	Nature genetics	2006	132
16832050	polyglutamine	Duennwald ML	Flanking sequences profoundly alter polyglutamine toxicity in yeast.	Proceedings of the National Academy of Sciences of the United States of America	2006	120
16980958	polyglutamine	Kitamura A	Cytosolic chaperonin prevents polyglutamine toxicity with altering the aggregation state.	Nature cell biology	2006	105
17041811	polyglutamine	Borrell-Pagès M	Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies.	Cellular and molecular life sciences 	2006	62
17118264	polyglutamine	Williams A	Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications.	Current topics in developmental biology	2006	109
17240289	polyglutamine	Walker FO	Huntington's disease.	Lancet	2007	358
18337722	polyglutamine	Lim J	Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1.	Nature	2008	130
18466116	polyglutamine	Imarisio S	Huntington's disease: from pathology and genetics to potential therapies.	The Biochemical journal	2008	113
18957430	polyglutamine	Zoghbi HY	Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1.	The Journal of biological chemistry	2009	70
19269181	polyglutamine	Caviston JP	Huntingtin as an essential integrator of intracellular vesicular trafficking.	Trends in cell biology	2009	90
19270701	polyglutamine	Thakur AK	Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism.	Nature structural & molecular biology	2009	134
19361997	polyglutamine	Pfister EL	Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients.	Current biology 	2009	85
19487684	polyglutamine	Nekooki-Machida Y	Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity.	Proceedings of the National Academy of Sciences of the United States of America	2009	81
20026656	polyglutamine	Thompson LM	IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome.	The Journal of cell biology	2009	115
20159555	polyglutamine	Hageman J	A DNAJB chaperone subfamily with HDAC-dependent activities suppresses toxic protein aggregation.	Molecular cell	2010	84
20220138	polyglutamine	Legleiter J	Mutant huntingtin fragments form oligomers in a polyglutamine length-dependent manner in vitro and in vivo.	The Journal of biological chemistry	2010	69
20236390	polyglutamine	Han I	Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.	Journal of neurochemistry	2010	41
20444706	polyglutamine	Olshina MA	Tracking mutant huntingtin aggregation kinetics in cells reveals three major populations that include an invariant oligomer pool.	The Journal of biological chemistry	2010	40
20665636	polyglutamine	McConoughey SJ	Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease.	EMBO molecular medicine	2010	50
21163446	polyglutamine	Ross CA	Huntington's disease: from molecular pathogenesis to clinical treatment.	The Lancet. Neurology	2011	293
21247881	polyglutamine	de Mezer M	Mutant CAG repeats of Huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference.	Nucleic acids research	2011	61
22200539	polyglutamine	Arrasate M	Protein aggregates in Huntington's disease.	Experimental neurology	2012	66
22306404	polyglutamine	Wetzel R	Physical chemistry of polyglutamine: intriguing tales of a monotonous sequence.	Journal of molecular biology	2012	59
22383888	polyglutamine	Bañez-Coronel M	A pathogenic mechanism in Huntington's disease involves small CAG-repeated RNAs with neurotoxic activity.	PLoS genetics	2012	50
22433867	polyglutamine	Nucifora LG	Identification of novel potentially toxic oligomers formed in vitro from mammalian-derived expanded huntingtin exon-1 protein.	The Journal of biological chemistry	2012	34
23781027	polyglutamine	Costanzo M	Transfer of polyglutamine aggregates in neuronal cells occurs in tunneling nanotubes.	Journal of cell science	2013	46
23873212	polyglutamine	Tsvetkov AS	Proteostasis of polyglutamine varies among neurons and predicts neurodegeneration.	Nature chemical biology	2013	45
25282404	polyglutamine	Martin DD	Autophagy in Huntington disease and huntingtin in autophagy.	Trends in neurosciences	2015	42
25723488	polyglutamine	Lim J	Proteotoxic stress induces phosphorylation of p62/SQSTM1 by ULK1 to regulate selective autophagic clearance of protein aggregates.	PLoS genetics	2015	38
26590344	polyglutamine	Bañez-Coronel M	RAN Translation in Huntington Disease.	Neuron	2015	39
27106072	polyglutamine	Kampinga HH	Heat shock proteins as potential targets for protective strategies in neurodegeneration.	The Lancet. Neurology	2016	11
27188817	polyglutamine	Bates GP	Huntington disease.	Nature reviews. Disease primers	2015	54
17622601	Hypoglycemic Agents	Amori RE	Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis.	JAMA	2007	209
17638885	Hypoglycemic Agents	Buzzai M	Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth.	Cancer research	2007	307
18158075	Hypoglycemic Agents	Barnett AH	Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.	Clinical therapeutics	2007	62
18782641	Hypoglycemic Agents	Drucker DJ	Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study.	Lancet	2008	212
19515413	Hypoglycemic Agents	Buse JB	Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).	Lancet	2009	310
20448207	Hypoglycemic Agents	Oeseburg H	Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.	Arteriosclerosis, thrombosis, and vascular biology	2010	61
21307137	Hypoglycemic Agents	Blevins T	DURATION-5: exenatide once weekly resulted in greater improvements in glycemic control compared with exenatide twice daily in patients with type 2 diabetes.	The Journal of clinical endocrinology and metabolism	2011	75
22236411	Hypoglycemic Agents	Vilsbøll T	Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials.	BMJ	2012	128
23521863	Hypoglycemic Agents	Moiseeva O	Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-κB activation.	Aging cell	2013	38
25011946	Hypoglycemic Agents	Diamant M	Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes.	Diabetes care	2014	24
15743917	Allopurinol	Hung SI	HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.	Proceedings of the National Academy of Sciences of the United States of America	2005	139
19018717	Allopurinol	Kaniwa N	HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis.	Pharmacogenomics	2008	53
19696695	Allopurinol	Tassaneeyakul W	Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.	Pharmacogenetics and genomics	2009	60
21162721	Allopurinol	Harr T	Toxic epidermal necrolysis and Stevens-Johnson syndrome.	Orphanet journal of rare diseases	2010	70
21912425	Allopurinol	Tohkin M	A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients.	The pharmacogenomics journal	2013	27
23232549	Allopurinol	Hershfield MS	Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing.	Clinical pharmacology and therapeutics	2013	37
25115449	Allopurinol	Chung WH	Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin.	Annals of the rheumatic diseases	2015	25
26094938	Allopurinol	Saito Y	Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update.	Clinical pharmacology and therapeutics	2016	11
27339448	Allopurinol	Kumagai T	Time to target uric acid to retard CKD progression.	Clinical and experimental nephrology	2017	5
28100272	Allopurinol	Sweileh WM	Bibliometric analysis of literature on toxic epidermal necrolysis and Stevens-Johnson syndrome: 1940 - 2015.	Orphanet journal of rare diseases	2017	6
19027483	docetaxel	Kim ES	Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial.	Lancet	2008	278
20519679	docetaxel	Swain SM	Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer.	The New England journal of medicine	2010	59
20807808	docetaxel	Zhu ML	Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer.	Cancer research	2010	87
21991949	docetaxel	Slamon D	Adjuvant trastuzumab in HER2-positive breast cancer.	The New England journal of medicine	2011	395
22149875	docetaxel	Baselga J	Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.	The New England journal of medicine	2012	444
23883922	docetaxel	Garassino MC	Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial.	The Lancet. Oncology	2013	127
24740322	docetaxel	Liu C	Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancer.	Clinical cancer research 	2014	61
24831979	docetaxel	Gregorc V	Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial.	The Lancet. Oncology	2014	44
7505800	Glycosylphosphatidylinositols	Hailman E	Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14.	The Journal of experimental medicine	1994	129
7542010	Glycosylphosphatidylinositols	Ulevitch RJ	Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin.	Annual review of immunology	1995	268
9751057	Glycosylphosphatidylinositols	Yang RB	Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling.	Nature	1998	200
9841923	Glycosylphosphatidylinositols	Kirschning CJ	Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide.	The Journal of experimental medicine	1998	127
11951093	Glycosylphosphatidylinositols	Nichols BJ	A distinct class of endosome mediates clathrin-independent endocytosis to the Golgi complex.	Nature cell biology	2002	89
12072369	Glycosylphosphatidylinositols	Triantafilou M	Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster.	Trends in immunology	2002	143
16341206	Glycosylphosphatidylinositols	Glebov OO	Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells.	Nature cell biology	2006	160
18088084	Glycosylphosphatidylinositols	Hassan R	Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin.	Cancer immunity	2007	65
22444671	Glycosylphosphatidylinositols	Ng BG	Mutations in the glycosylphosphatidylinositol gene PIGL cause CHIME syndrome.	American journal of human genetics	2012	34
7629501	Mannose	Sallusto F	Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products.	The Journal of experimental medicine	1995	442
12515819	Mannose	Tailleux L	DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells.	The Journal of experimental medicine	2003	143
17241663	Mannose	van Liempt E	Schistosoma mansoni soluble egg antigens are internalized by human dendritic cells through multiple C-type lectins and suppress TLR-induced dendritic cell activation.	Molecular immunology	2007	83
20554962	Mannose	Rajaram MV	Mycobacterium tuberculosis activates human macrophage peroxisome proliferator-activated receptor gamma linking mannose receptor recognition to regulation of immune responses.	Journal of immunology	2010	71
23454681	Mannose	Jaguin M	Polarization profiles of human M-CSF-generated macrophages and comparison of M1-markers in classically activated macrophages from GM-CSF and M-CSF origin.	Cellular immunology	2013	72
24192057	Mannose	Kleinnijenhuis J	Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity.	Journal of innate immunity	2014	28
25216635	Mannose	Kang JH	An extracorporeal blood-cleansing device for sepsis therapy.	Nature medicine	2014	37
8152488	Amyloid beta-Peptides	Lorenzo A	Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus.	Nature	1994	165
11580253	Amyloid beta-Peptides	Kirkitadze MD	Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis.	Journal of molecular biology	2001	151
11815632	Amyloid beta-Peptides	Zhang Y	Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons.	The Journal of cell biology	2002	96
12815044	Amyloid beta-Peptides	Der-Sarkissian A	Structural organization of alpha-synuclein fibrils studied by site-directed spin labeling.	The Journal of biological chemistry	2003	97
16567625	Amyloid beta-Peptides	Mahley RW	Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	2006	230
17046788	Amyloid beta-Peptides	Yan Y	Abeta42 is more rigid than Abeta40 at the C terminus: implications for Abeta aggregation and toxicity.	Journal of molecular biology	2006	64
18675468	Amyloid beta-Peptides	Bezprozvanny I	Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease.	Trends in neurosciences	2008	233
19759000	Amyloid beta-Peptides	Noguchi A	Isolation and characterization of patient-derived, toxic, high mass amyloid beta-protein (Abeta) assembly from Alzheimer disease brains.	The Journal of biological chemistry	2009	48
20393191	Amyloid beta-Peptides	De Strooper B	Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process.	Physiological reviews	2010	112
15172732	Neurotoxins	Klein WL	Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease.	Neurobiology of aging	2004	126
15217615	Neurotoxins	Edwards DJ	Structure and biosynthesis of the jamaicamides, new mixed polyketide-peptide neurotoxins from the marine cyanobacterium Lyngbya majuscula.	Chemistry & biology	2004	114
16796601	Neurotoxins	Brabers NA	Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia.	European journal of clinical investigation	2006	86
17239913	Neurotoxins	Catterall WA	Voltage-gated ion channels and gating modifier toxins.	Toxicon 	2007	139
25548474	Acetaldehyde	Ceni E	Pathogenesis of alcoholic liver disease: role of oxidative metabolism.	World journal of gastroenterology	2014	34
12514169	Acetylmuramyl-Alanyl-Isoglutamine	Inohara N	Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease.	The Journal of biological chemistry	2003	405
16021602	Acetylmuramyl-Alanyl-Isoglutamine	Fritz JH	Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists.	European journal of immunology	2005	70
18032608	Acetylmuramyl-Alanyl-Isoglutamine	Hedl M	Chronic stimulation of Nod2 mediates tolerance to bacterial products.	Proceedings of the National Academy of Sciences of the United States of America	2007	93
16860916	bisphenol A	Kang JH	Human exposure to bisphenol A.	Toxicology	2006	70
19654912	bisphenol A	Bouskine A	Low doses of bisphenol A promote human seminoma cell proliferation by activating PKA and PKG via a membrane G-protein-coupled estrogen receptor.	Environmental health perspectives	2009	47
22949852	bisphenol A	Singh S	Epigenetic effects of environmental chemicals bisphenol A and phthalates.	International journal of molecular sciences	2012	52
22562770	Benzo(a)pyrene	Tang WY	Maternal exposure to polycyclic aromatic hydrocarbons and 5'-CpG methylation of interferon-γ in cord white blood cells.	Environmental health perspectives	2012	41
25605026	Benzo(a)pyrene	Moffat I	Comparison of toxicogenomics and traditional approaches to inform mode of action and points of departure in human health risk assessment of benzoapyrene in drinking water.	Critical reviews in toxicology	2015	16
8905098	Arsenic	Silver S	Bacterial heavy metal resistance: new surprises.	Annual review of microbiology	1996	140
21321970	Arsenic	Jomova K	Arsenic: toxicity, oxidative stress and human disease.	Journal of applied toxicology 	2011	92
21554949	Arsenic	Flora SJ	Arsenic-induced oxidative stress and its reversibility.	Free radical biology & medicine	2011	88
22383894	Arsenic	Pierce BL	Genome-wide association study identifies chromosome 10q24.32 variants associated with arsenic metabolism and toxicity phenotypes in Bangladesh.	PLoS genetics	2012	55
22551203	Arsenic	Intarasunanont P	Effects of arsenic exposure on DNA methylation in cord blood samples from newborn babies and in a human lymphoblast cell line.	Environmental health 	2012	42
25304211	Arsenic	Rojas D	Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes.	Toxicological sciences 	2015	37
25739736	Arsenic	Schlebusch CM	Human adaptation to arsenic-rich environments.	Molecular biology and evolution	2015	21
26771251	Arsenic	Green BB	Epigenome-Wide Assessment of DNA Methylation in the Placenta and Arsenic Exposure in the New Hampshire Birth Cohort Study (USA).	Environmental health perspectives	2016	13
16799634	decitabine	Wozniak RJ	5-Aza-2'-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation.	Oncogene	2007	59
19221000	decitabine	Majid S	BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer.	Carcinogenesis	2009	60
20124447	decitabine	Zhang P	Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth.	Molecular cancer therapeutics	2010	112
21540125	decitabine	Rajender S	Epigenetics, spermatogenesis and male infertility.	Mutation research	2011	39
22237753	decitabine	Sun CY	Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation.	Kidney international	2012	35
24806409	decitabine	Liu EY	C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD.	Acta neuropathologica	2014	42
16622124	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	Yaguchi S	Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor.	Journal of the National Cancer Institute	2006	70
23466500	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	Yang SM	miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN.	Toxicology	2013	45
9048659	SB 203580	Huot J	Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells.	Circulation research	1997	107
12509443	SB 203580	Frevel MA	p38 Mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts.	Molecular and cellular biology	2003	92
15033490	SB 203580	Wulster-Radcliffe MC	Adiponectin differentially regulates cytokines in porcine macrophages.	Biochemical and biophysical research communications	2004	96
27454768	SB 203580	Li C	Quercetin inhibits LPS-induced adhesion molecule expression and oxidant production in human aortic endothelial cells by p38-mediated Nrf2 activation and antioxidant enzyme induction.	Redox biology	2016	11
3926894	Polymyxin B	Shalaby MR	Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors.	Journal of immunology	1985	173
10364168	Polymyxin B	Schwandner R	Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2.	The Journal of biological chemistry	1999	357
12403778	Polymyxin B	Gao B	Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor alpha release by murine macrophages.	The Journal of biological chemistry	2003	85
18354232	Polymyxin B	Youn JH	High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes.	Journal of immunology	2008	74
12573486	Tetrachlorodibenzodioxin	Mimura J	Functional role of AhR in the expression of toxic effects by TCDD.	Biochimica et biophysica acta	2003	89
15900503	Tetrachlorodibenzodioxin	Mandal PK	Dioxin: a review of its environmental effects and its aryl hydrocarbon receptor biology.	Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology	2005	67
17823304	Tetrachlorodibenzodioxin	Vogel CF	RelB, a new partner of aryl hydrocarbon receptor-mediated transcription.	Molecular endocrinology	2007	83
20511231	Tetrachlorodibenzodioxin	DiNatale BC	Mechanistic insights into the events that lead to synergistic induction of interleukin 6 transcription upon activation of the aryl hydrocarbon receptor and inflammatory signaling.	The Journal of biological chemistry	2010	44
21976023	Tetrachlorodibenzodioxin	Opitz CA	An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor.	Nature	2011	276
24302727	Tetrachlorodibenzodioxin	Vogel CF	Cross-talk between aryl hydrocarbon receptor and the inflammatory response: a role for nuclear factor-κB.	The Journal of biological chemistry	2014	45
24655296	Tetrachlorodibenzodioxin	Stockinger B	The aryl hydrocarbon receptor: multitasking in the immune system.	Annual review of immunology	2014	86
27243009	Tetrachlorodibenzodioxin	Mulero-Navarro S	New Trends in Aryl Hydrocarbon Receptor Biology.	Frontiers in cell and developmental biology	2016	19
17363489	temozolomide	Thomas HD	Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial.	Molecular cancer therapeutics	2007	64
20439646	temozolomide	Stupp R	Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma.	Journal of clinical oncology 	2010	99
24552318	temozolomide	Chinot OL	Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.	The New England journal of medicine	2014	358
25163906	temozolomide	Stupp R	Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial.	The Lancet. Oncology	2014	126
25762461	temozolomide	Nabors LB	Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study.	Neuro-oncology	2015	30
26431379	temozolomide	Yu Z	Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo.	Oncotarget	2015	22
27503200	temozolomide	Gojo I	A Phase 1 Study of the PARP Inhibitor Veliparib in Combination with Temozolomide in Acute Myeloid Leukemia.	Clinical cancer research 	2017	7
7729872	Cytotoxins	Sharma SA	Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro.	Infection and immunity	1995	117
7834601	Cytotoxins	Jett BD	Virulence of enterococci.	Clinical microbiology reviews	1994	132
15170101	Cytotoxins	Kaneko J	Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes.	Bioscience, biotechnology, and biochemistry	2004	72
18390664	Cytotoxins	Gelber SE	Functional and phylogenetic characterization of Vaginolysin, the human-specific cytolysin from Gardnerella vaginalis.	Journal of bacteriology	2008	65
10843709	resveratrol	Manna SK	Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation.	Journal of immunology	2000	133
19471118	resveratrol	Demidenko ZN	At concentrations that inhibit mTOR, resveratrol suppresses cellular senescence.	Cell cycle	2009	52
20622002	resveratrol	Tili E	Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD.	Carcinogenesis	2010	61
21980390	resveratrol	Roy SK	Resveratrol inhibits growth of orthotopic pancreatic tumors through activation of FOXO transcription factors.	PloS one	2011	40
22055504	resveratrol	Timmers S	Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans.	Cell metabolism	2011	236
24606795	resveratrol	Valero T	Mitochondrial biogenesis: pharmacological approaches.	Current pharmaceutical design	2014	29
25440059	resveratrol	Scheibye-Knudsen M	A high-fat diet and NAD(+) activate Sirt1 to rescue premature aging in cockayne syndrome.	Cell metabolism	2014	52
9660876	sphingosine 1-phosphate	Van Brocklyn JR	Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival.	The Journal of cell biology	1998	106
10545499	sphingosine 1-phosphate	Olivera A	Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival.	The Journal of cell biology	1999	127
15013522	sphingosine 1-phosphate	Reynolds CP	Ceramide synthesis and metabolism as a target for cancer therapy.	Cancer letters	2004	84
20502000	sphingosine 1-phosphate	Kornhuber J	Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications.	Cellular physiology and biochemistry 	2010	42
15607931	oxaliplatin	Chaney SG	Recognition and processing of cisplatin- and oxaliplatin-DNA adducts.	Critical reviews in oncology/hematology	2005	69
21103969	oxaliplatin	Nies AT	Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy.	Handbook of experimental pharmacology	2011	79
21641636	oxaliplatin	Maughan TS	Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.	Lancet	2011	219
21709185	oxaliplatin	Crane CH	Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression.	Journal of clinical oncology 	2011	68
22627104	oxaliplatin	Rödel C	Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial.	The Lancet. Oncology	2012	100
23102520	oxaliplatin	Cervantes A	Current questions for the treatment of advanced gastric cancer.	Cancer treatment reviews	2013	35
23811849	oxaliplatin	Yamazaki T	Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists.	Cell death and differentiation	2014	40
24465408	oxaliplatin	Nangia-Makker P	Metformin: a potential therapeutic agent for recurrent colon cancer.	PloS one	2014	30
25877855	oxaliplatin	Tabernero J	Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.	The Lancet. Oncology	2015	92
26189067	oxaliplatin	Rödel C	Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.	The Lancet. Oncology	2015	41
27055731	oxaliplatin	Nywening TM	Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial.	The Lancet. Oncology	2016	40
28270698	oxaliplatin	Alexander JL	Gut microbiota modulation of chemotherapy efficacy and toxicity.	Nature reviews. Gastroenterology & hepatology	2017	9
20062057	4-hydroxy-2-nonenal	Perez-Miller S	Alda-1 is an agonist and chemical chaperone for the common human aldehyde dehydrogenase 2 variant.	Nature structural & molecular biology	2010	58
20218676	4-hydroxy-2-nonenal	Jacobs AT	Systems analysis of protein modification and cellular responses induced by electrophile stress.	Accounts of chemical research	2010	68
22698681	4-hydroxy-2-nonenal	Kauppinen A	Oxidative stress activates NLRP3 inflammasomes in ARPE-19 cells--implications for age-related macular degeneration (AMD).	Immunology letters	2012	54
24096871	4-hydroxy-2-nonenal	Dalleau S	Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance.	Cell death and differentiation	2013	50
11474661	Immunotoxins	Kreitman RJ	Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia.	The New England journal of medicine	2001	96
15758046	Immunotoxins	Matsusaka T	Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury.	Journal of the American Society of Nephrology 	2005	75
16061911	Immunotoxins	Kreitman RJ	Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-cell malignancies.	Journal of clinical oncology 	2005	80
17025272	Immunotoxins	Kreitman RJ	Immunotoxins for targeted cancer therapy.	The AAPS journal	2006	79
17878392	Immunotoxins	Powell DJ Jr	Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo.	Journal of immunology	2007	56
18403491	Immunotoxins	Sampson JH	Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors.	Neuro-oncology	2008	55
20215554	Immunotoxins	Wayne AS	Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trial.	Clinical cancer research 	2010	57
21034418	Immunotoxins	Seon BK	Endoglin-targeted cancer therapy.	Current drug delivery	2011	47
26864110	Immunotoxins	Mazor R	Immunogenicity of therapeutic recombinant immunotoxins.	Immunological reviews	2016	19
18511942	epigallocatechin gallate	Ehrnhoefer DE	EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers.	Nature structural & molecular biology	2008	225
20730621	epigallocatechin gallate	Jomova K	Metals, oxidative stress and neurodegenerative disorders.	Molecular and cellular biochemistry	2010	164
21796625	epigallocatechin gallate	Tang SN	Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics.	International journal of cancer	2012	50
21827739	epigallocatechin gallate	Singh BN	Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications.	Biochemical pharmacology	2011	171
11815407	Curcumin	Ireson CR	Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine.	Cancer epidemiology, biomarkers & prevention 	2002	86
15383533	Curcumin	Balasubramanyam K	Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription.	The Journal of biological chemistry	2004	176
16151628	Curcumin	Elsharkawy AM	The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis.	Apoptosis 	2005	98
17332326	Curcumin	Li M	Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway.	Cancer research	2007	70
18834508	Curcumin	Sa G	Anti cancer effects of curcumin: cycle of life and death.	Cell division	2008	51
19590964	Curcumin	Ravindran J	Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?	The AAPS journal	2009	125
23076367	Curcumin	Huang T	Curcumin inhibits LPS-induced EMT through downregulation of NF-κB-Snail signaling in breast cancer cells.	Oncology reports	2013	26
23509976	Curcumin	Singh PK	Curcumin modulates α-synuclein aggregation and toxicity.	ACS chemical neuroscience	2013	30
28249988	Curcumin	Wang J	Curcumin improves intestinal barrier function: modulation of intracellular signaling, and organization of tight junctions.	American journal of physiology. Cell physiology	2017	5
19332058	Poly Adenosine Diphosphate Ribose	Wang Y	Poly(ADP-ribose) signals to mitochondrial AIF: a key event in parthanatos.	Experimental neurology	2009	98
20133863	Poly Adenosine Diphosphate Ribose	Hegan DC	Inhibition of poly(ADP-ribose) polymerase down-regulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130.	Proceedings of the National Academy of Sciences of the United States of America	2010	50
21821475	Poly Adenosine Diphosphate Ribose	Helleday T	The underlying mechanism for the PARP and BRCA synthetic lethality: clearing up the misunderstandings.	Molecular oncology	2011	141
24598253	Poly Adenosine Diphosphate Ribose	Beck C	PARP3 affects the relative contribution of homologous recombination and nonhomologous end-joining pathways.	Nucleic acids research	2014	22
24814482	Poly Adenosine Diphosphate Ribose	Pirinen E	Pharmacological Inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle.	Cell metabolism	2014	42
2644022	globotriaosylceramide	Karmali MA	Infection by verocytotoxin-producing Escherichia coli.	Clinical microbiology reviews	1989	350
7890387	CAP18 lipopolysaccharide-binding protein	Larrick JW	Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein.	Infection and immunity	1995	121
9736536	CAP18 lipopolysaccharide-binding protein	Turner J	Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils.	Antimicrobial agents and chemotherapy	1998	161
16456005	CAP18 lipopolysaccharide-binding protein	Mookherjee N	Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37.	Journal of immunology	2006	114
16716248	CAP18 lipopolysaccharide-binding protein	Dürr UH	LL-37, the only human member of the cathelicidin family of antimicrobial peptides.	Biochimica et biophysica acta	2006	179
20049649	CAP18 lipopolysaccharide-binding protein	Bucki R	Cathelicidin LL-37: a multitask antimicrobial peptide.	Archivum immunologiae et therapiae experimentalis	2010	47
26556394	CAP18 lipopolysaccharide-binding protein	Xhindoli D	The human cathelicidin LL-37--A pore-forming antibacterial peptide and host-cell modulator.	Biochimica et biophysica acta	2016	18
20000589	Indican	Schroeder JC	The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor.	Biochemistry	2010	55
23325087	Indican	Watanabe H	p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase.	Kidney international	2013	35
8915011	beta-Defensins	Zhao C	Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells.	FEBS letters	1996	116
10521347	beta-Defensins	Yang D	Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6.	Science	1999	349
15385474	beta-Defensins	Wehkamp J	NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium.	Infection and immunity	2004	85
15494486	beta-Defensins	Vora P	Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells.	Journal of immunology	2004	83
20104491	beta-Defensins	Semple F	Human beta-defensin 3 has immunosuppressive activity in vitro and in vivo.	European journal of immunology	2010	43
16115877	Poly I-C	Cusson-Hermance N	Rip1 mediates the Trif-dependent toll-like receptor 3- and 4-induced NF-{kappa}B activation but does not contribute to interferon regulatory factor 3 activation.	The Journal of biological chemistry	2005	89
17068485	Poly I-C	Lebre MC	Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9.	The Journal of investigative dermatology	2007	90
19360120	Poly I-C	Stahl-Hennig C	Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques.	PLoS pathogens	2009	75
20610642	Poly I-C	Benko S	NLRC5 limits the activation of inflammatory pathways.	Journal of immunology	2010	58
21563279	Poly I-C	Cassatella MA	Toll-like receptor-3-activated human mesenchymal stromal cells significantly prolong the survival and function of neutrophils.	Stem cells	2011	39
24321786	Poly I-C	Zhan Z	Autophagy facilitates TLR4- and TLR3-triggered migration and invasion of lung cancer cells through the promotion of TRAF6 ubiquitination.	Autophagy	2014	30
16359182	sulforafan	Hong F	Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane.	Chemical research in toxicology	2005	98
17555985	sulforafan	Dashwood RH	Dietary histone deacetylase inhibitors: from cells to mice to man.	Seminars in cancer biology	2007	90
23589329	sulforafan	Lau A	Arsenic inhibits autophagic flux, activating the Nrf2-Keap1 pathway in a p62-dependent manner.	Molecular and cellular biology	2013	36
24025640	sulforafan	Jiang T	Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-κB-mediated inflammatory response.	Kidney international	2014	25
10622253	lysophosphatidic acid	Prenzel N	EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF.	Nature	1999	350
19609003	lysophosphatidic acid	Li TT	Beta-arrestin/Ral signaling regulates lysophosphatidic acid-mediated migration and invasion of human breast tumor cells.	Molecular cancer research 	2009	52
24706986	lysophosphatidic acid	Haak AJ	Targeting the myofibroblast genetic switch: inhibitors of myocardin-related transcription factor/serum response factor-regulated gene transcription prevent fibrosis in a murine model of skin injury.	The Journal of pharmacology and experimental therapeutics	2014	26
26740622	lysophosphatidic acid	Kedziora KM	Rapid Remodeling of Invadosomes by Gi-coupled Receptors: DISSECTING THE ROLE OF Rho GTPases.	The Journal of biological chemistry	2016	12
17241619	androstane	Guillouzo A	The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics.	Chemico-biological interactions	2007	70
17608617	androstane	Pascussi JM	The tangle of nuclear receptors that controls xenobiotic metabolism and transport: crosstalk and consequences.	Annual review of pharmacology and toxicology	2008	70
19427329	androstane	di Masi A	Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects.	Molecular aspects of medicine	2009	55
26962021	androstane	Cave MC	Nuclear receptors and nonalcoholic fatty liver disease.	Biochimica et biophysica acta	2016	13
27889186	androstane	Kettner NM	Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis.	Cancer cell	2016	21
19692684	gefitinib	Rosell R	Screening for epidermal growth factor receptor mutations in lung cancer.	The New England journal of medicine	2009	495
20573926	gefitinib	Maemondo M	Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.	The New England journal of medicine	2010	1115
21252289	gefitinib	Minematsu T	Interactions of tyrosine kinase inhibitors with organic cation transporters and multidrug and toxic compound extrusion proteins.	Molecular cancer therapeutics	2011	37
25563590	gefitinib	Moody TW	EGFR Transactivation by Peptide G Protein-Coupled Receptors in Cancer.	Current drug targets	2016	11
10632283	Alanine	Sulkowski MS	Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.	JAMA	2000	121
18291570	Alanine	Ozer J	The current state of serum biomarkers of hepatotoxicity.	Toxicology	2008	146
18940312	Alanine	Yuan X	Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes.	American journal of human genetics	2008	122
26769963	Alanine	Chang YJ	The Glycine-Alanine Dipeptide Repeat from C9orf72 Hexanucleotide Expansions Forms Toxic Amyloids Possessing Cell-to-Cell Transmission Properties.	The Journal of biological chemistry	2016	12
27224670	Alanine	Mikus M	Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury.	Liver international 	2017	7
28119464	Alanine	Nystoriak MA	Ser1928 phosphorylation by PKA stimulates the L-type Ca2+ channel CaV1.2 and vasoconstriction during acute hyperglycemia and diabetes.	Science signaling	2017	9
28514450	Alanine	Liu Y	Evolutionary enhancement of Zika virus infectivity in Aedes aegypti mosquitoes.	Nature	2017	31
10201887	Amino Acids	Hoshino K	Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product.	Journal of immunology	1999	769
14530974	Amino Acids	Kanai Y	The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects.	Pflugers Archiv 	2004	75
14579113	Amino Acids	Hagenbuch B	Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties.	Pflugers Archiv 	2004	175
14761977	Amino Acids	Zhang Z	MDM2 is a negative regulator of p21WAF1/CIP1, independent of p53.	The Journal of biological chemistry	2004	72
17261713	Amino Acids	Bano D	Ca2+ signals and neuronal death in brain ischemia.	Stroke	2007	56
17360675	Amino Acids	Urano J	Point mutations in TOR confer Rheb-independent growth in fission yeast and nutrient-independent mammalian TOR signaling in mammalian cells.	Proceedings of the National Academy of Sciences of the United States of America	2007	67
18802454	Amino Acids	Rutherford NJ	Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis.	PLoS genetics	2008	154
19582903	Amino Acids	de Lartigue J	PIKfyve regulation of endosome-linked pathways.	Traffic	2009	49
19797270	Amino Acids	Rudolph TK	Transduction of redox signaling by electrophile-protein reactions.	Science signaling	2009	65
20693280	Amino Acids	Varkey J	Membrane curvature induction and tubulation are common features of synucleins and apolipoproteins.	The Journal of biological chemistry	2010	80
26590448	Amino Acids	Ramezani A	Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.	American journal of kidney diseases 	2016	17
27998952	Amino Acids	Hinks A	Fine-mapping the MHC locus in juvenile idiopathic arthritis (JIA) reveals genetic heterogeneity corresponding to distinct adult inflammatory arthritic diseases.	Annals of the rheumatic diseases	2017	6
28261941	Amino Acids	Takahashi RH	Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.	Pathology international	2017	10
17192538	lapatinib	Geyer CE	Lapatinib plus capecitabine for HER2-positive advanced breast cancer.	The New England journal of medicine	2006	629
19179558	lapatinib	Blackwell KL	Single-agent lapatinib for HER2-overexpressing advanced or metastatic breast cancer that progressed on first- or second-line trastuzumab-containing regimens.	Annals of oncology 	2009	51
23122784	lapatinib	Bachelot T	Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study.	The Lancet. Oncology	2013	84
24095300	lapatinib	Robidoux A	Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial.	The Lancet. Oncology	2013	61
26204261	lapatinib	Moasser MM	The Evolving Landscape of HER2 Targeting in Breast Cancer.	JAMA oncology	2015	15
18955133	beta-amyloid peptide 1-42 (E22delta) click peptide	Waxman EA	Molecular mechanisms of alpha-synuclein neurodegeneration.	Biochimica et biophysica acta	2009	60
19339619	beta-amyloid peptide 1-42 (E22delta) click peptide	Mandrekar S	Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis.	The Journal of neuroscience 	2009	125
19465477	beta-amyloid peptide 1-42 (E22delta) click peptide	Johnson BS	TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity.	The Journal of biological chemistry	2009	198
19657023	beta-amyloid peptide 1-42 (E22delta) click peptide	Tampellini D	Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations.	The Journal of neuroscience 	2009	50
19951690	beta-amyloid peptide 1-42 (E22delta) click peptide	Sun B	Imbalance between GABAergic and Glutamatergic Transmission Impairs Adult Neurogenesis in an Animal Model of Alzheimer's Disease.	Cell stem cell	2009	52
20164570	beta-amyloid peptide 1-42 (E22delta) click peptide	Butterfield DA	Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration.	Journal of Alzheimer's disease 	2010	58
20713699	beta-amyloid peptide 1-42 (E22delta) click peptide	Sandberg A	Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering.	Proceedings of the National Academy of Sciences of the United States of America	2010	83
20844121	beta-amyloid peptide 1-42 (E22delta) click peptide	Crews L	Increased BMP6 levels in the brains of Alzheimer's disease patients and APP transgenic mice are accompanied by impaired neurogenesis.	The Journal of neuroscience 	2010	44
21252259	beta-amyloid peptide 1-42 (E22delta) click peptide	Sandler NG	Plasma levels of soluble CD14 independently predict mortality in HIV infection.	The Journal of infectious diseases	2011	383
23703910	beta-amyloid peptide 1-42 (E22delta) click peptide	Cohen SI	Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism.	Proceedings of the National Academy of Sciences of the United States of America	2013	170
25995210	beta-amyloid peptide 1-42 (E22delta) click peptide	Vaisar T	Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity.	Journal of lipid research	2015	20
20823850	vemurafenib	Bollag G	Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma.	Nature	2010	468
21639808	vemurafenib	Chapman PB	Improved survival with vemurafenib in melanoma with BRAF V600E mutation.	The New England journal of medicine	2011	1658
25037139	vemurafenib	Ribas A	Combination of vemurafenib and cobimetinib in patients with advanced BRAF(V600)-mutated melanoma: a phase 1b study.	The Lancet. Oncology	2014	36
25096067	vemurafenib	Kim G	FDA approval summary: vemurafenib for treatment of unresectable or metastatic melanoma with the BRAFV600E mutation.	Clinical cancer research 	2014	21
22663011	trametinib	Flaherty KT	Improved survival with MEK inhibition in BRAF-mutated melanoma.	The New England journal of medicine	2012	423
22805291	trametinib	Infante JR	Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial.	The Lancet. Oncology	2012	94
23020132	trametinib	Flaherty KT	Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations.	The New England journal of medicine	2012	596
24764582	trametinib	Vella LJ	MEK inhibition, alone or in combination with BRAF inhibition, affects multiple functions of isolated normal human lymphocytes and dendritic cells.	Cancer immunology research	2014	34
25265492	trametinib	Long GV	Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma.	The New England journal of medicine	2014	232
28891408	trametinib	Long GV	Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.	The New England journal of medicine	2017	10
